Evaluation of intranasal delivery route of drug administration for brain targeting
[Display omitted] •The two main pathways of intranasal drug absorption are the olfactory and trigeminal routes.•The intranasal drugs can bypass the blood-brain barrier and blood-CSF barrier.•There are in vitro, ex vivo and in vivo models for testing drug penetration by intranasal route.•The drug pen...
Saved in:
| Published in: | Brain research bulletin Vol. 143; pp. 155 - 170 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01.10.2018
|
| Subjects: | |
| ISSN: | 0361-9230, 1873-2747, 1873-2747 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | [Display omitted]
•The two main pathways of intranasal drug absorption are the olfactory and trigeminal routes.•The intranasal drugs can bypass the blood-brain barrier and blood-CSF barrier.•There are in vitro, ex vivo and in vivo models for testing drug penetration by intranasal route.•The drug penetartion from nasal cavity can be enhanced by various formulations and devices.•Transporter modulation can also help in nasal delivery of their substrates.
The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting. |
|---|---|
| AbstractList | The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting. The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting.The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting. [Display omitted] •The two main pathways of intranasal drug absorption are the olfactory and trigeminal routes.•The intranasal drugs can bypass the blood-brain barrier and blood-CSF barrier.•There are in vitro, ex vivo and in vivo models for testing drug penetration by intranasal route.•The drug penetartion from nasal cavity can be enhanced by various formulations and devices.•Transporter modulation can also help in nasal delivery of their substrates. The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting. |
| Author | Farkas, Dániel Bajza, Ágnes Erdő, Franciska Gizurarson, Sveinbjörn Bors, Luca Anna |
| Author_xml | – sequence: 1 givenname: Franciska surname: Erdő fullname: Erdő, Franciska email: erdo.franciska@itk.ppke.hu organization: Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Práter u. 50A, H-1083 Budapest, Hungary – sequence: 2 givenname: Luca Anna surname: Bors fullname: Bors, Luca Anna organization: Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Práter u. 50A, H-1083 Budapest, Hungary – sequence: 3 givenname: Dániel surname: Farkas fullname: Farkas, Dániel organization: Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Práter u. 50A, H-1083 Budapest, Hungary – sequence: 4 givenname: Ágnes surname: Bajza fullname: Bajza, Ágnes organization: Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Práter u. 50A, H-1083 Budapest, Hungary – sequence: 5 givenname: Sveinbjörn orcidid: 0000-0001-7824-9752 surname: Gizurarson fullname: Gizurarson, Sveinbjörn organization: Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, 107 Reykjavík, Iceland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30449731$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1uEzEURi1URNPCK6ARKzYTfGfGHg8roBRaqRJSVdaWf-5EDo6n2J5IeXucpJVQV1l5cb_v2Pf4gpyFKSAhH4AugQL_tF7qqFyImPTs_bKhIMpgSenwiixA9G3d9F1_Rha05VAPTUvPyUVKa0opF4y_Iect7bqhb2FB7q-3ys8quylU01i5kKMKKilfWfRui3FXxWnOuB_aOK8qZTcuuFRih844xerwmiqruMLswuoteT0qn_Dd03lJfv-4fri6qe9-_by9-npXG8b6XGvRMN4wIfRoQWsjuKbMGgYIIAA7MyhFe6Op7tnYCAscgDJuxo4ypZuhvSQfj9zHOP2dMWW5ccmg9yrgNCfZQMt41w7ASvT9U3TWG7TyMbqNijv57KEEvhwDJk4pRRylcfmwYVnUeQlU7tXLtfxfvdyr38-K-oL4_ALxfMtJ5e_HMhZhW4dRJuMwGLQuosnSTu40zLcXGOPLbxnl_-DuVMg_9I2_Mw |
| CitedBy_id | crossref_primary_10_2147_IJN_S525960 crossref_primary_10_1002_bdd_2348 crossref_primary_10_1016_j_intimp_2024_113853 crossref_primary_10_1016_j_tvjl_2019_105346 crossref_primary_10_3390_jcm10081754 crossref_primary_10_3390_pharmaceutics14102174 crossref_primary_10_1080_17425247_2019_1684895 crossref_primary_10_17221_21_2023_VETMED crossref_primary_10_4103_tcmj_tcmj_99_24 crossref_primary_10_3390_pharmaceutics13070969 crossref_primary_10_1016_j_vaa_2023_02_001 crossref_primary_10_1186_s43094_024_00665_7 crossref_primary_10_1016_j_jddst_2023_105007 crossref_primary_10_3390_ph15030370 crossref_primary_10_3389_fphys_2021_815758 crossref_primary_10_3390_gels11040260 crossref_primary_10_2174_1872210515666210531112006 crossref_primary_10_3390_pharmaceutics15051399 crossref_primary_10_1016_j_jddst_2021_102642 crossref_primary_10_1016_j_apmt_2021_101303 crossref_primary_10_2196_67132 crossref_primary_10_1016_j_jddst_2024_105658 crossref_primary_10_1016_j_jddst_2021_102648 crossref_primary_10_1093_rpsppr_rqac003 crossref_primary_10_1021_acsmaterialslett_5c00698 crossref_primary_10_3390_molecules26237351 crossref_primary_10_1002_ddr_21903 crossref_primary_10_3390_pharmaceutics14102070 crossref_primary_10_1016_j_bbih_2021_100251 crossref_primary_10_1016_j_vaa_2022_08_003 crossref_primary_10_1038_s41684_025_01545_0 crossref_primary_10_1007_s13346_020_00891_5 crossref_primary_10_3390_biom11040543 crossref_primary_10_1155_2022_4054938 crossref_primary_10_1016_j_ijpharm_2022_121853 crossref_primary_10_1016_j_addr_2019_11_009 crossref_primary_10_1038_s41398_021_01511_7 crossref_primary_10_3389_fnagi_2023_1184435 crossref_primary_10_3390_antiox11050838 crossref_primary_10_1186_s12987_022_00330_2 crossref_primary_10_1002_adfm_202010674 crossref_primary_10_1016_j_jddst_2021_102791 crossref_primary_10_1016_j_jconrel_2022_01_044 crossref_primary_10_3390_cancers13112631 crossref_primary_10_3390_ijms24119648 crossref_primary_10_1177_2280800020977170 crossref_primary_10_2174_1381612826666200116153912 crossref_primary_10_3389_fphar_2021_754502 crossref_primary_10_1208_s12249_020_01872_0 crossref_primary_10_1186_s41983_023_00621_x crossref_primary_10_3390_biom9040154 crossref_primary_10_4103_1673_5374_358619 crossref_primary_10_3390_nano10071270 crossref_primary_10_3389_fncel_2022_892197 crossref_primary_10_3390_ijms232113383 crossref_primary_10_1080_03639045_2023_2262035 crossref_primary_10_1016_j_jddst_2022_103932 crossref_primary_10_1039_C9BM02006C crossref_primary_10_3390_ijms23158418 crossref_primary_10_3390_pharmaceutics13101673 crossref_primary_10_3390_ma14071802 crossref_primary_10_3390_pharmaceutics13030391 crossref_primary_10_1016_j_mehy_2022_110996 crossref_primary_10_1007_s11051_020_05118_9 crossref_primary_10_1080_10837450_2020_1753771 crossref_primary_10_1080_17425247_2025_2489553 crossref_primary_10_1016_j_jconrel_2020_11_021 crossref_primary_10_1016_j_jconrel_2025_113604 crossref_primary_10_4103_ijmr_ijmr_847_22 crossref_primary_10_1016_j_ebiom_2022_103843 crossref_primary_10_1146_annurev_virology_012220_023606 crossref_primary_10_1016_j_ejphar_2025_177940 crossref_primary_10_1186_s12906_023_04125_2 crossref_primary_10_4103_NRR_NRR_D_24_00462 crossref_primary_10_1016_j_apsb_2021_02_012 crossref_primary_10_1016_j_ymthe_2021_06_019 crossref_primary_10_2217_nnm_2021_0418 crossref_primary_10_3390_pharmaceutics16010058 crossref_primary_10_3390_pharmaceutics13122167 crossref_primary_10_1007_s40005_021_00548_6 crossref_primary_10_1016_j_jconrel_2025_113711 crossref_primary_10_3390_molecules28031354 crossref_primary_10_3390_ijms24032917 crossref_primary_10_1080_1061186X_2023_2247583 crossref_primary_10_1016_j_ejpb_2022_11_003 crossref_primary_10_1016_j_ijpharm_2022_121720 crossref_primary_10_1186_s13063_022_06075_5 crossref_primary_10_2174_0115672018285350240227073607 crossref_primary_10_1002_ctd2_253 crossref_primary_10_18231_j_jpbs_2023_001 crossref_primary_10_1016_j_ejphar_2025_177958 crossref_primary_10_1080_00914037_2024_2443165 crossref_primary_10_3390_pharmaceutics16010066 crossref_primary_10_1021_acsomega_5c00364 crossref_primary_10_3390_ani13132076 crossref_primary_10_3389_fphar_2025_1572771 crossref_primary_10_1016_j_xphs_2019_07_012 crossref_primary_10_3390_gels9080610 crossref_primary_10_1208_s12249_025_03171_y crossref_primary_10_3389_fphar_2024_1435133 crossref_primary_10_1039_D3BM02003G crossref_primary_10_3390_scipharm87010006 crossref_primary_10_1016_j_biomaterials_2023_122277 crossref_primary_10_3390_molecules30092071 crossref_primary_10_1208_s12249_024_02974_9 crossref_primary_10_1016_j_jddst_2021_102517 crossref_primary_10_2217_nnm_2021_0311 crossref_primary_10_1002_cpt_3478 crossref_primary_10_3390_microorganisms11061554 crossref_primary_10_1161_CIRCRESAHA_119_316317 crossref_primary_10_2147_IJN_S337427 crossref_primary_10_3390_toxics13060482 crossref_primary_10_2147_IJN_S525759 crossref_primary_10_3390_pharmaceutics14122825 crossref_primary_10_3390_ph17080990 crossref_primary_10_1002_smll_202403564 crossref_primary_10_1016_j_arr_2022_101618 crossref_primary_10_1016_j_ijpharm_2024_124216 crossref_primary_10_3390_pharmaceutics15041216 crossref_primary_10_1080_14656566_2023_2292186 crossref_primary_10_1016_j_intimp_2019_105760 crossref_primary_10_3390_pharmaceutics15020533 crossref_primary_10_3389_fpsyg_2022_1042553 crossref_primary_10_36927_2079_0325_V31_is3_2023_11 crossref_primary_10_1016_j_jddst_2024_105677 crossref_primary_10_36927_2079_0325_V31_is3_2023_10 crossref_primary_10_3390_pharmaceutics14030631 crossref_primary_10_3390_biomedicines10020343 crossref_primary_10_3390_polym14194004 crossref_primary_10_1002_nbm_5149 crossref_primary_10_3389_fnins_2021_695592 crossref_primary_10_1016_j_jconrel_2021_12_030 crossref_primary_10_1016_j_jddst_2020_102098 crossref_primary_10_3389_fnins_2024_1517601 crossref_primary_10_3390_cells13231943 crossref_primary_10_3390_molecules26040916 crossref_primary_10_1016_j_jconrel_2021_12_034 crossref_primary_10_2174_1381612829666230803114513 crossref_primary_10_1016_j_jddst_2025_106857 crossref_primary_10_1016_j_xphs_2023_07_002 crossref_primary_10_1002_adma_202306583 crossref_primary_10_1515_zpch_2023_0221 crossref_primary_10_1007_s13346_023_01455_z crossref_primary_10_1016_j_ijpharm_2025_125692 crossref_primary_10_1016_j_jddst_2024_106581 crossref_primary_10_3390_pharmaceutics11100540 crossref_primary_10_1080_00914037_2024_2383412 crossref_primary_10_1016_j_addr_2022_114539 crossref_primary_10_1016_j_ijpharm_2020_119046 crossref_primary_10_21303_2504_5695_2022_002643 crossref_primary_10_3762_bjnano_15_113 crossref_primary_10_1016_j_jconrel_2021_04_020 crossref_primary_10_3390_pharmaceutics11030118 crossref_primary_10_1016_j_jddst_2022_103516 crossref_primary_10_1016_j_ijpharm_2022_122213 crossref_primary_10_4103_1673_5374_389624 crossref_primary_10_1007_s13346_025_01919_4 crossref_primary_10_4155_tde_2022_0018 crossref_primary_10_3390_biomedicines10071706 crossref_primary_10_1021_jacs_4c10733 crossref_primary_10_2147_IJN_S381353 crossref_primary_10_3390_pharmaceutics14030656 crossref_primary_10_1002_advs_202101058 crossref_primary_10_1002_dmrr_3409 crossref_primary_10_2147_IJN_S403707 crossref_primary_10_1016_j_ijpharm_2020_120040 crossref_primary_10_1002_adhm_202201989 crossref_primary_10_1007_s40272_024_00672_4 crossref_primary_10_1186_s13287_021_02274_0 crossref_primary_10_3390_pharmaceutics15082032 crossref_primary_10_1007_s00210_019_01715_1 crossref_primary_10_1016_j_curtheres_2021_100627 crossref_primary_10_1016_j_ijbiomac_2025_146761 crossref_primary_10_3389_fphar_2023_1227423 crossref_primary_10_1186_s12951_022_01605_4 crossref_primary_10_1038_s41598_019_42261_3 crossref_primary_10_1007_s13346_022_01245_z crossref_primary_10_1016_j_brainresbull_2020_04_012 crossref_primary_10_1016_j_dsx_2022_102478 crossref_primary_10_1016_j_drudis_2022_103371 crossref_primary_10_3897_pharmacia_71_e120458 crossref_primary_10_1016_j_euroneuro_2021_04_010 crossref_primary_10_3390_biomedicines8010013 crossref_primary_10_3389_fimmu_2021_714179 crossref_primary_10_3762_bjnano_11_72 crossref_primary_10_1016_j_jddst_2022_103656 crossref_primary_10_3389_fphar_2021_717192 crossref_primary_10_1016_j_jddst_2024_106254 crossref_primary_10_3390_pharmaceutics17091147 crossref_primary_10_1007_s00520_025_09189_z crossref_primary_10_3390_polym14142963 crossref_primary_10_3390_vetsci10080490 crossref_primary_10_1021_acsptsci_5c00560 crossref_primary_10_1080_10717544_2022_2110996 crossref_primary_10_1016_j_addr_2023_114861 crossref_primary_10_2147_IJN_S258791 crossref_primary_10_1161_STROKEAHA_123_044422 crossref_primary_10_3390_ph17060720 crossref_primary_10_3390_pharmaceutics15030998 crossref_primary_10_1080_02652048_2021_1986585 crossref_primary_10_3390_ph18050615 crossref_primary_10_1016_j_xphs_2025_103903 crossref_primary_10_1016_j_ijpharm_2021_121141 crossref_primary_10_1016_j_ijpharm_2024_125125 crossref_primary_10_1016_j_ijpharm_2022_121683 crossref_primary_10_1007_s40005_022_00597_5 crossref_primary_10_1016_j_addr_2020_10_018 crossref_primary_10_3390_pharmaceutics15061660 crossref_primary_10_1016_j_jconrel_2020_03_042 crossref_primary_10_3390_pharmaceutics17050675 crossref_primary_10_1002_bdd_2400 crossref_primary_10_1667_RADE_20_00070_1 crossref_primary_10_1016_j_neuropharm_2021_108832 crossref_primary_10_3390_pharmaceutics16040519 crossref_primary_10_1007_s00210_021_02196_x crossref_primary_10_1016_j_jddst_2021_102597 crossref_primary_10_4103_1673_5374_306062 crossref_primary_10_1177_01926233221089209 crossref_primary_10_3390_pharmaceutics15122658 crossref_primary_10_1016_j_arr_2024_102357 crossref_primary_10_1016_j_npep_2021_102182 crossref_primary_10_1080_17425247_2020_1762563 crossref_primary_10_3390_pharmaceutics15122773 crossref_primary_10_3390_pharmaceutics15082119 crossref_primary_10_3390_pharmaceutics13111897 crossref_primary_10_3390_ph18060871 crossref_primary_10_1016_j_ijbiomac_2021_04_045 crossref_primary_10_1016_j_jddst_2023_105095 crossref_primary_10_1016_j_jddst_2024_106125 crossref_primary_10_1080_02652048_2023_2282968 crossref_primary_10_1186_s43094_023_00530_z crossref_primary_10_1007_s13346_020_00739_y crossref_primary_10_3390_pharmaceutics17091177 crossref_primary_10_2174_0929867329666220224112811 crossref_primary_10_1007_s12640_022_00555_x crossref_primary_10_1016_j_ejps_2021_105918 crossref_primary_10_1038_s41380_025_02898_1 crossref_primary_10_1002_nep3_42 crossref_primary_10_3390_geriatrics7020024 crossref_primary_10_3390_pharmaceutics12050476 crossref_primary_10_1016_j_ijpharm_2021_121244 crossref_primary_10_2174_0122103031273192240102054301 crossref_primary_10_1016_j_matpr_2022_11_221 crossref_primary_10_3390_pharmaceutics13081183 crossref_primary_10_1007_s00210_021_02096_0 crossref_primary_10_1021_acs_molpharmaceut_5c00297 crossref_primary_10_3390_molecules28237706 crossref_primary_10_1016_j_bbr_2023_114594 crossref_primary_10_1007_s11051_023_05880_6 crossref_primary_10_3389_fnana_2025_1641228 crossref_primary_10_3390_pharmaceutics17091104 crossref_primary_10_13005_bbra_3207 crossref_primary_10_1177_00236772241241561 crossref_primary_10_3390_colloids7010023 crossref_primary_10_1016_j_jconrel_2022_12_026 crossref_primary_10_1007_s13346_022_01285_5 crossref_primary_10_2147_IJN_S417928 crossref_primary_10_1039_D1BM01251G crossref_primary_10_3390_biomedicines11082198 crossref_primary_10_2147_IJN_S402447 crossref_primary_10_3390_bioengineering10020253 crossref_primary_10_3390_ijms23073678 crossref_primary_10_2217_nnm_2021_0164 crossref_primary_10_3390_pharmaceutics13050680 crossref_primary_10_1016_j_jddst_2020_101606 crossref_primary_10_3390_pharmaceutics14051048 crossref_primary_10_1016_j_jddst_2019_101375 crossref_primary_10_1016_j_ijpharm_2021_120933 crossref_primary_10_1016_j_jconrel_2021_02_024 crossref_primary_10_2174_0122103031253788231020060301 crossref_primary_10_3390_pharmaceutics13050686 crossref_primary_10_1016_j_ccr_2024_215926 crossref_primary_10_3390_pharmaceutics14020323 crossref_primary_10_1007_s11095_020_02829_5 crossref_primary_10_1210_endrev_bnaf008 crossref_primary_10_1016_j_ijbiomac_2025_143542 crossref_primary_10_1016_j_jddst_2021_103059 crossref_primary_10_3390_cancers14020410 crossref_primary_10_2217_nnm_2021_0169 crossref_primary_10_1016_j_jddst_2024_106393 crossref_primary_10_1111_epi_17341 crossref_primary_10_3390_app9112219 crossref_primary_10_1146_annurev_chembioeng_092220_030853 crossref_primary_10_3389_fnins_2021_700729 crossref_primary_10_1177_0192623320958684 crossref_primary_10_1155_adpp_5585693 crossref_primary_10_1016_j_ebr_2022_100581 crossref_primary_10_1016_j_jddst_2021_103087 crossref_primary_10_3390_pharmaceutics13081144 crossref_primary_10_1002_wnan_1696 crossref_primary_10_1016_j_ijpharm_2025_125197 crossref_primary_10_1016_j_taap_2023_116754 crossref_primary_10_3390_md20050335 crossref_primary_10_1016_j_ijpharm_2020_119582 crossref_primary_10_1007_s00210_025_04172_1 crossref_primary_10_3389_fphar_2021_652473 crossref_primary_10_2174_0115748855299918240529063242 crossref_primary_10_1039_D4NR01056F crossref_primary_10_1016_j_cellsig_2023_110668 crossref_primary_10_1016_j_addr_2024_115363 crossref_primary_10_1186_s12931_020_01343_x crossref_primary_10_1007_s10847_022_01149_y crossref_primary_10_3390_polysaccharides6010006 crossref_primary_10_3389_fped_2025_1542482 crossref_primary_10_1016_j_nantod_2024_102169 crossref_primary_10_1080_17460441_2020_1776697 crossref_primary_10_1093_jtm_taad026 crossref_primary_10_1016_j_jconrel_2025_01_018 crossref_primary_10_3390_pharmaceutics15071999 crossref_primary_10_3390_pharmaceutics13060795 crossref_primary_10_1016_j_hest_2025_01_002 crossref_primary_10_1002_anbr_202100019 crossref_primary_10_1016_j_jaim_2020_02_001 crossref_primary_10_1161_CIRCRESAHA_120_317999 crossref_primary_10_1208_s12249_025_03100_z crossref_primary_10_2174_1381612829666221024124848 crossref_primary_10_2174_1570180820666230407110243 crossref_primary_10_1186_s43088_022_00319_8 crossref_primary_10_3390_ijms222312860 crossref_primary_10_1016_j_ejps_2021_106089 crossref_primary_10_1080_10837450_2021_1916032 crossref_primary_10_3390_biomedicines10050985 crossref_primary_10_1016_j_ejps_2023_106623 crossref_primary_10_1016_j_bmc_2022_116913 crossref_primary_10_1002_wnan_1993 crossref_primary_10_1016_j_ecoenv_2024_116569 crossref_primary_10_1016_j_colsurfb_2021_111838 crossref_primary_10_1016_j_ecoenv_2025_118963 crossref_primary_10_3390_pharmaceutics14051003 crossref_primary_10_1111_ejn_15447 crossref_primary_10_3390_pharmaceutics14061195 crossref_primary_10_1016_j_biopha_2024_116899 crossref_primary_10_1038_s41573_020_0078_4 crossref_primary_10_1124_jpet_121_000530 crossref_primary_10_1080_10837450_2021_1950186 crossref_primary_10_5812_aapm_130452 crossref_primary_10_4103_1673_5374_320966 crossref_primary_10_1155_jnt_7697122 crossref_primary_10_3390_pharmaceutics16040481 crossref_primary_10_1002_anbr_202100120 crossref_primary_10_1016_j_drudis_2019_10_005 crossref_primary_10_1111_jvp_13056 crossref_primary_10_3390_pharmaceutics14030576 crossref_primary_10_1016_j_jddst_2025_107122 crossref_primary_10_1016_j_jddst_2025_107000 crossref_primary_10_3390_pharmaceutics14030572 crossref_primary_10_1016_j_ijbiomac_2024_134962 crossref_primary_10_1111_1440_1681_13737 crossref_primary_10_1002_adtp_202000076 crossref_primary_10_1038_s41586_022_04661_w crossref_primary_10_1002_wnan_1768 crossref_primary_10_3390_pharmaceutics14061283 crossref_primary_10_12968_jpar_2024_0017 crossref_primary_10_1016_j_jddst_2022_103569 crossref_primary_10_3390_children9050644 crossref_primary_10_3390_antib10040047 crossref_primary_10_1136_bcr_2020_239261 crossref_primary_10_1016_j_jddst_2023_104970 crossref_primary_10_3390_nano12132267 crossref_primary_10_1007_s44174_025_00428_9 crossref_primary_10_3390_pharmaceutics14030588 crossref_primary_10_1007_s10876_025_02832_z crossref_primary_10_1039_D5NR00870K crossref_primary_10_47419_bjbabs_v4i01_178 crossref_primary_10_1016_j_ijpharm_2023_123748 crossref_primary_10_1016_j_jconrel_2023_06_026 crossref_primary_10_1016_j_lfs_2022_120797 crossref_primary_10_3389_fphar_2022_1068495 crossref_primary_10_1016_j_vaa_2024_10_134 crossref_primary_10_1016_S1474_4422_20_30231_3 crossref_primary_10_4155_tde_2023_0019 crossref_primary_10_2147_IJN_S506456 crossref_primary_10_3390_pharmaceutics15061720 crossref_primary_10_1128_AAC_02106_20 crossref_primary_10_3390_pharmaceutics14061178 crossref_primary_10_3389_fnmol_2023_1174125 crossref_primary_10_1111_imm_13300 crossref_primary_10_1016_j_ijpharm_2020_119832 crossref_primary_10_1111_aphw_12310 crossref_primary_10_1016_j_physbeh_2024_114583 crossref_primary_10_1007_s10989_019_09971_8 crossref_primary_10_1080_1061186X_2020_1817041 crossref_primary_10_1016_j_cclet_2022_07_034 crossref_primary_10_3390_cells12121643 crossref_primary_10_1002_EXP_20210115 crossref_primary_10_3390_nano11010159 crossref_primary_10_1016_j_addr_2023_115114 crossref_primary_10_1080_17425247_2022_2029845 crossref_primary_10_47419_bjbabs_v4i02_178 crossref_primary_10_3390_pharmaceutics15112583 crossref_primary_10_1016_j_jpba_2024_115988 crossref_primary_10_1080_17425247_2021_1823965 crossref_primary_10_1016_j_jconrel_2020_09_002 crossref_primary_10_1007_s40005_021_00528_w crossref_primary_10_1016_j_euroneuro_2023_03_008 crossref_primary_10_1016_j_jconrel_2020_06_028 crossref_primary_10_3390_pharmaceutics13010026 crossref_primary_10_1016_j_tvjl_2024_106065 crossref_primary_10_3390_ijms22168453 crossref_primary_10_3389_fmed_2024_1463976 crossref_primary_10_1002_wnan_1956 crossref_primary_10_1016_j_jconrel_2023_04_021 crossref_primary_10_1016_j_peptides_2020_170312 crossref_primary_10_2147_IJN_S240551 crossref_primary_10_1080_17425247_2025_2539958 crossref_primary_10_1016_j_ejmech_2024_117195 crossref_primary_10_3389_fphar_2022_927812 crossref_primary_10_1063_5_0284305 crossref_primary_10_3390_biomedicines9121834 crossref_primary_10_1007_s12015_023_10642_x crossref_primary_10_2147_IJN_S518486 crossref_primary_10_3390_pharmaceutics12020192 crossref_primary_10_1016_j_cis_2024_103341 crossref_primary_10_1007_s13346_025_01912_x crossref_primary_10_3390_mi14010112 crossref_primary_10_1016_j_jconrel_2021_08_027 crossref_primary_10_1016_j_neulet_2022_136821 crossref_primary_10_1089_adt_2022_051 crossref_primary_10_12968_jpar_2024_0053 crossref_primary_10_1177_10915818231152613 crossref_primary_10_1016_j_jconrel_2023_12_054 crossref_primary_10_2147_OAEM_S244110 crossref_primary_10_2147_IJN_S520768 crossref_primary_10_1007_s11095_024_03790_3 crossref_primary_10_1016_j_ijpharm_2024_124400 crossref_primary_10_1016_j_ijpharm_2021_120881 crossref_primary_10_3390_pharmaceutics13122069 crossref_primary_10_1016_j_xphs_2025_103780 crossref_primary_10_1111_jnc_15956 crossref_primary_10_3390_pharmaceutics16070849 crossref_primary_10_1002_agt2_403 crossref_primary_10_3390_polym13142241 crossref_primary_10_3390_biomedicines12010198 crossref_primary_10_1002_wnan_1853 crossref_primary_10_3390_polym14030443 crossref_primary_10_1080_1061186X_2022_2119243 crossref_primary_10_3390_ijms24010690 crossref_primary_10_3390_pharmaceutics16030350 crossref_primary_10_1208_s12249_021_01999_8 crossref_primary_10_3390_pharmaceutics12020097 crossref_primary_10_1088_2516_1091_ad776c crossref_primary_10_1016_j_jconrel_2020_07_044 crossref_primary_10_1186_s12967_024_04908_2 crossref_primary_10_1016_j_jddst_2023_104473 crossref_primary_10_3390_pharmaceutics14102252 crossref_primary_10_1002_adhm_202102610 crossref_primary_10_1088_1361_6528_ad1c95 crossref_primary_10_1007_s12274_023_6188_7 crossref_primary_10_3389_fcell_2023_1214450 crossref_primary_10_3390_biomedicines9111734 crossref_primary_10_1021_acsami_5c01920 crossref_primary_10_2147_IJN_S369978 crossref_primary_10_1186_s43094_020_00158_3 crossref_primary_10_2147_IJN_S442801 crossref_primary_10_3389_fneur_2021_669449 crossref_primary_10_3390_pharmaceutics16101297 crossref_primary_10_1016_j_jconrel_2021_01_027 crossref_primary_10_1007_s10787_023_01274_1 crossref_primary_10_1080_01932691_2025_2488455 crossref_primary_10_3389_fphar_2023_1224856 crossref_primary_10_3389_fbioe_2023_1168408 crossref_primary_10_1007_s12668_022_00998_8 crossref_primary_10_1161_STROKEAHA_120_032444 crossref_primary_10_54133_ajms_v8i1_1692 crossref_primary_10_3389_fbioe_2020_626882 crossref_primary_10_26538_tjnpr_v9i8_39 crossref_primary_10_3390_cells11213445 crossref_primary_10_1002_prp2_587 crossref_primary_10_1038_s41467_020_15942_1 crossref_primary_10_1080_00498254_2019_1709228 crossref_primary_10_1016_j_addr_2021_113832 crossref_primary_10_1002_EXP_20240036 crossref_primary_10_1016_j_ijpharm_2021_120724 crossref_primary_10_3390_ph14080711 crossref_primary_10_3390_ph16020311 crossref_primary_10_1016_j_biopha_2023_115407 crossref_primary_10_1038_s41386_025_02107_1 crossref_primary_10_1053_j_semnuclmed_2025_05_002 crossref_primary_10_1177_1098612X251360418 crossref_primary_10_3390_molecules25215188 crossref_primary_10_3390_molecules28135206 crossref_primary_10_1080_14786419_2024_2345760 crossref_primary_10_1016_j_ijpharm_2022_122061 crossref_primary_10_1093_rpsppr_rqad021 crossref_primary_10_1016_j_jds_2024_11_029 crossref_primary_10_1002_btm2_10426 crossref_primary_10_1371_journal_ppat_1012412 crossref_primary_10_1109_JTEHM_2024_3503498 crossref_primary_10_1080_17425247_2022_2074975 crossref_primary_10_1186_s13578_023_01052_0 crossref_primary_10_4103_2221_1691_369611 crossref_primary_10_1186_s12974_024_03264_8 crossref_primary_10_3390_biomedicines12122865 crossref_primary_10_3390_gels8010038 crossref_primary_10_1208_s12249_024_02736_7 crossref_primary_10_3390_molecules28073023 crossref_primary_10_1016_j_jpba_2025_116945 crossref_primary_10_3390_pharmaceutics11020064 crossref_primary_10_1016_j_ejmech_2023_115613 |
| Cites_doi | 10.1172/JCI33009 10.1007/s10517-010-0929-9 10.4333/KPS.2010.40.6.321 10.1016/j.ijbiomac.2014.03.022 10.1097/00005344-199108000-00006 10.1073/pnas.192442999 10.1016/j.bbamem.2008.09.016 10.1213/01.ane.0000226150.90317.16 10.1073/pnas.82.21.7419 10.1016/j.jneuroim.2010.04.014 10.3109/1061186X.2010.523787 10.1111/j.1464-5491.1992.tb01792.x 10.1038/jcbfm.2008.158 10.1016/S0378-5173(02)00077-7 10.1210/en.2005-1016 10.1038/nature03701 10.1016/S0895-7061(98)00095-8 10.1016/j.brainresbull.2011.11.004 10.1016/j.ejps.2005.01.009 10.1016/S0378-5173(03)00039-5 10.1016/S0014-2999(00)00540-9 10.1016/j.lfs.2017.12.025 10.3233/JAD-122308 10.1002/ar.20592 10.3109/03639045.2010.539231 10.2741/e209 10.1016/j.ijpharm.2006.02.055 10.1007/BF02758299 10.1186/1471-2210-7-7 10.1177/088307380201700206 10.1136/bmj.282.6259.212 10.1155/2014/309342 10.3390/ph11010009 10.1080/10717544.2017.1377316 10.1097/00004714-200008000-00009 10.1016/S0168-3659(02)00363-2 10.3233/JAD-1998-1102 10.1016/j.neulet.2008.04.003 10.1016/j.vaa.2017.06.003 10.1136/bmj.321.7253.83 10.1001/archpediatrics.2010.130 10.1007/s00418-008-0410-2 10.1016/j.ijpharm.2016.09.086 10.1211/jpp.61.05.0017 10.1038/nn0602-849 10.1016/j.ijpharm.2016.05.010 10.1016/j.ijpharm.2009.06.019 10.3109/10717544.2012.752421 10.1007/s13346-012-0108-9 10.1016/j.ijpharm.2015.12.046 10.1016/j.jddst.2016.05.003 10.1517/17425247.2013.790887 10.1023/A:1016418523014 10.1016/j.jconrel.2007.05.026 10.1016/j.addr.2011.11.002 10.1089/jamp.2011.0924 10.1371/journal.pone.0197101 10.1210/jc.2005-0906 10.1007/s11095-004-9013-3 10.1016/j.eplepsyres.2013.02.018 10.1038/nm919 10.1016/j.jconrel.2017.09.001 10.1517/17425247.5.10.1159 10.1016/j.neulet.2003.12.005 10.1016/j.biopsych.2009.09.020 10.1016/j.ejps.2013.03.012 10.1254/jphs.93.437 10.1007/s11095-012-0915-1 10.1016/j.psyneuen.2004.04.003 10.2174/1389200043489126 10.1002/jps.21031 10.1016/S0169-409X(97)00064-1 10.4103/2231-4040.90876 10.1007/s10517-010-1058-1 10.1016/0378-5173(95)04416-7 10.1210/jc.2007-2606 10.1038/npp.2010.123 10.1124/jpet.102.036129 10.1016/S0169-409X(97)00067-7 10.1096/fj.10-180133 10.1016/j.ejps.2017.02.032 10.1016/S0022-3565(24)39336-X 10.1016/S0169-409X(97)00058-6 10.1111/j.1749-6632.1998.tb10551.x 10.1016/j.ejpb.2009.08.008 10.1215/15228517-2007-052 10.1016/j.pediatrneurol.2005.09.006 10.1097/WAD.0b013e318157205b 10.1211/jpp.58.1.0008 10.3389/fimmu.2017.01133 10.1124/jpet.107.132381 10.2174/156720112803529828 10.1016/j.nbd.2009.02.011 10.1161/HYPERTENSIONAHA.113.02860 10.1155/2014/156010 10.1007/s00415-012-6659-3 10.1001/archneurol.2011.233 10.1248/bpb.22.425 10.1007/s12031-013-9993-8 10.1210/en.2002-220982 10.1248/bpb.17.316 10.1177/0300985816629712 10.1016/j.peptides.2010.10.030 10.1016/S0169-409X(97)00059-8 10.1016/j.jneuroim.2004.02.011 10.1073/pnas.0500195102 10.1016/S0006-3223(03)00465-7 10.1016/j.brainresbull.2006.02.020 10.1007/s12035-011-8229-6 10.1007/BF02991098 10.2174/1381612043384862 10.1023/A:1025053115583 10.1016/j.actbio.2011.07.025 10.1016/S0196-9781(99)00139-4 10.1016/j.neurobiolaging.2005.03.016 10.1016/j.peptides.2011.03.016 10.1124/jpet.116.235192 10.1016/j.ejps.2006.11.018 10.1023/A:1016210231121 10.1021/mp400735c 10.1016/S1359-6446(02)02452-2 10.1016/j.jcf.2004.05.026 10.1016/j.xphs.2015.12.016 10.1007/s00280-005-0018-3 10.3389/fphar.2018.00027 10.1093/brain/awn193 10.1016/j.eplepsyres.2014.04.007 10.3317/jraas.2001.019 10.1016/0092-8674(95)90273-2 10.1073/pnas.91.15.7114 10.1111/j.2042-7158.1985.tb05069.x 10.1016/S0928-0987(01)00151-8 10.1523/JNEUROSCI.3878-07.2007 10.1016/S0378-5173(03)00341-7 10.1523/JNEUROSCI.3984-05.2005 10.3390/ijms131114127 10.2174/156720106777731118 10.1016/S0928-0987(00)00087-7 10.1016/j.ijpharm.2005.06.012 10.1016/0378-5173(88)90277-3 10.1007/BF02975453 10.1517/17425247.2014.894504 10.1016/j.ejps.2012.04.013 10.1016/j.neulet.2008.09.030 10.1007/s11095-009-9907-1 10.1016/j.neulet.2009.06.060 10.1007/s11095-004-1191-5 10.3109/10717544.2011.557785 10.1089/scd.2017.0148 10.3390/pharmaceutics10010034 10.1016/j.eplepsyres.2012.07.018 10.1016/j.neulet.2008.10.090 10.1016/j.brainresbull.2017.07.006 10.1186/1471-2202-9-S3-S5 10.1016/j.yebeh.2004.01.003 10.3233/JAD-150307 10.2147/IJN.S61288 10.1602/neurorx.2.1.3 10.1016/S0169-409X(97)00061-6 10.1073/pnas.0403172101 10.2337/diabetes.48.3.557 10.1016/j.biopsych.2006.07.015 10.2337/db10-0329 10.1021/acs.molpharmaceut.5b00088 10.1080/10717540802006377 10.1111/j.1398-9995.1999.tb04402.x 10.1007/s13346-012-0111-1 10.1002/jps.21924 10.1111/j.1749-6632.1998.tb10595.x 10.1161/ATVBAHA.109.202671 10.1111/j.1528-1167.2009.02333.x 10.1186/1471-2202-9-117 10.1016/j.yebeh.2015.04.027 10.1016/j.lfs.2018.06.032 10.1002/ana.22070 10.1016/j.ymthe.2005.12.013 |
| ContentType | Journal Article |
| Copyright | 2018 The Authors Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2018 The Authors – notice: Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.brainresbull.2018.10.009 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1873-2747 |
| EndPage | 170 |
| ExternalDocumentID | 30449731 10_1016_j_brainresbull_2018_10_009 S0361923018303678 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K --M -~X .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 41~ 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABTEW ABUFD ABWVN ABXDB ACDAQ ACGFO ACGFS ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPKN AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMQ HVGLF HZ~ IHE J1W KOM M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SNS SPCBC SSN SSZ T5K WUQ Z5R ZGI ~G- ~HD 0SF 6I. AACTN AADPK AAFTH AAIAV ABYKQ ADKLL AFCTW AFKWA AFMIJ AJBFU AJOXV AMFUW RIG 9DU AAYXX CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c557t-b82562588bfd1bbc86b05dc51e1181e4c9aa07cb0b75f28d1611056cf405ab293 |
| ISICitedReferencesCount | 559 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000452813700018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0361-9230 1873-2747 |
| IngestDate | Thu Oct 02 12:12:31 EDT 2025 Wed Feb 19 02:36:01 EST 2025 Sat Nov 29 07:18:53 EST 2025 Tue Nov 18 21:20:27 EST 2025 Fri Feb 23 02:33:34 EST 2024 Tue Oct 14 19:35:35 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | IFN-β1b BBB EPO AUC ANG II RPMI 2650 l-DOPA V1 V2 V3 Delivery enhancer techniques AD P-gp FGF PACAP IN FST EN IGF-1 Intranasal administration NGF OEC LCC IL-6 TST CNS indication ADNP E ONF CNS Drug delivery SC IF γ MCP1 Transporter interactions CSF GA MSC MCAO GLP-1 CaCo-2 MOG SCA-1 VEGF OSN HIV PD scFv TJ TEER TGF-β1 PK HD ALI GALP |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c557t-b82562588bfd1bbc86b05dc51e1181e4c9aa07cb0b75f28d1611056cf405ab293 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-7824-9752 |
| OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S0361923018303678 |
| PMID | 30449731 |
| PQID | 2135643915 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_2135643915 pubmed_primary_30449731 crossref_citationtrail_10_1016_j_brainresbull_2018_10_009 crossref_primary_10_1016_j_brainresbull_2018_10_009 elsevier_sciencedirect_doi_10_1016_j_brainresbull_2018_10_009 elsevier_clinicalkey_doi_10_1016_j_brainresbull_2018_10_009 |
| PublicationCentury | 2000 |
| PublicationDate | October 2018 2018-10-00 20181001 |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Brain research bulletin |
| PublicationTitleAlternate | Brain Res Bull |
| PublicationYear | 2018 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Rakover, Zabavnik, Kopel, Paz-Rozner, Solomon (bib0765) 2010; 225 De Haan, Van Der Geest, Doelman, Bertram, Edelbroek (bib0185) 2010; 51 Seju, Kumar, Sawant (bib0820) 2011; 7 Shiryaev, Jouroukhin, Giladi, Polyzoidou, Grigoriadis, Rosenmann, Gozes (bib0840) 2009; 34 Lindup, Orme (bib0585) 1981; 282 Shahaf, Hadash (bib0825) 2016 Fazil, Md, Haque, Kumar, Baboota, Sahni, Ali (bib0270) 2012; 47 Graff, Pollack (bib0355) 2005; 22 Micieli, Santangelo, Napoleone, Di Dona, Mennonna, Vesce (bib0640) 2017; 44 Khan, Patil, Yeole, Gaikwad (bib0515) 2009; 61 Lungare, Bowen, Badhan (bib0605) 2016; 105 Mangilal, Rao Patnaik (bib0625) 2014; 6 Chaturvedi, Kumar, Pathak (bib0120) 2011; 2 Gray (bib0375) 1978 Kang, Digicaylioglu, Russo, Kaul, Achim, Fletcher, Masliah, Lipton (bib0490) 2010; 68 Banks (bib0030) 2004; 10 Craven, Neuberger, Paterson, Webb, Josephson, Morrison, Settles (bib0160) 2007; 290 Dalpiaz, Ferraro, Perrone, Leo, Iannuccelli, Pavan, Paganetto, Beggiato, Scalia (bib0180) 2014; 11 Banks, Goulet, Rusche, Niehoff, Boismenu (bib0040) 2002; 302 . Smolnik, Perras, Molle, Fehm, Born (bib0855) 2000; 20 Proctor, Anderson (bib0755) 1982 Behl, Pimplaskar, Sileno, Xia, Gries, DeMeireles, Romeo (bib0055) 1998; 29 Jogani, Shah, Mishra, Mishra, Misra (bib0470) 2008; 22 Mittal, Manohar, Rawat (bib0655) 2006; 73 Drejer, Vaag, Bech, Hansen, Sørensen, Mygind (bib0245) 1992; 9 Fehm, Perras, Smolnik, Kern, Born (bib0275) 2000 Kürti, Gáspár, Márki, Kápolna, Bocsik, Veszelka, Bartos, Ambrus, Vastag, Deli, Szabó-Révész (bib0555) 2013; 50 Gozes, Giladi, Pinhasov, Bardea, Brenneman (bib0350) 2000; 293 Dyer, Hinchcliffe, Watts, Castile, Jabbal-Gill, Nankervis, Smith, Illum (bib0260) 2002; 19 Kirsch (bib0520) 2005; 25 Pardridge (bib0735) 2005; 2 Hoang, Uchenna, Mark, Renaat, Norbert (bib0430) 2002; 238 Monti-Bloch, Jennings-White, Berliner (bib0670) 1998 Klingenberg, Lebens, Hermansson, Fredrikson, Strodthoff, Rudling, Ketelhuth, Gerdes, Holmgren, Nilsson, Hansson (bib0525) 2010; 30 Laing, Gober, Golembewski, Thompson, Gyure, Yarowsky, Aurelian (bib0565) 2006; 13 Benedict, Hallschmid, Hatke, Schultes, Fehm, Born, Kern (bib0065) 2004; 29 Labuschagne, Phan, Wood, Angstadt, Chua, Heinrichs, Stout, Nathan (bib0560) 2010; 35 Najafabadi, Moslemi, Tajerzadeh (bib0690) 2004; 11 Nijboer, Kooijman, van Velthoven, Van Tilborg, Tiebosch, Eijkelkamp, Dijkhuizen, Kesecioglu, Heijnen (bib0705) 2018 Nonaka, Farr, Kageyama, Shioda, Banks (bib0710) 2008; 325 Wang, Gao, Yun (bib0905) 2006; 57 Guastella, Einfeld, Gray, Rinehart, Tonge, Lambert, Hickie (bib0385) 2010; 67 Ma, Ma, Cheng, Ma, Yi, Xu, Liu (bib0615) 2008; 437 Hardy, Lee, Wilson (bib0410) 1985; 37 Lochhead, Thorne (bib0590) 2012; 64 Streisand, Stanley (bib0870) 1995; 6 Guillot, Audus (bib0390) 1991; 1 Graff, Pollack (bib0360) 2004; 5 Capsoni, Giannotta, Cattaneo (bib0100) 2002; 99 Bates (bib0050) 2014 Kern, Born, Schreiber, Fehm (bib0505) 1999; 48 Lu, Zhao, Wong, Cai, Peng, Tian (bib0595) 2014; 9 Zhu, Cheng, Xu, Ma, Zhou, Liu, Liu (bib0980) 2011; 18 Wu, Hu, Jiang (bib0960) 2008; 5 Gizurarson (bib0320) 1990; 2 Li, Sheppard, Hug (bib0580) 2004; 3 Karasulu, Yavaşoǧlu, Evrenşanal, Uyanikgil, Karasulu (bib0500) 2008; 15 Sato, Nave, Nonaka, Yoshihisa, Atsuhiro, Mochizuki, Takahama, Kondo, Wingertzahn (bib0800) 2007; 7 Pennington, Ratcliffe, Wilson, Hardy (bib0745) 1988; 43 Alcalay, Giladi, Pick, Gozes (bib0010) 2004; 361 Hashizume, Ozawa, Gryaznov, Bollen, Lamborn, Frey, Deen (bib0415) 2008; 10 Lei, Feng, Duan, Xu, Liu, Lian, Liang, Zhang, Wang (bib0570) 2017; 134 Fleegal-Demotta, Doghu, Banks (bib0290) 2009; 29 Hsuchou, Mishra, Kastin, Wu, Wang, Ouyang, Pan (bib0445) 2013; 51 Kosfeld, Heinrichs, Zak, Fischbacher, Fehr (bib0530) 2005; 435 Ma, Ma, Yi, Guo, Zhu, Fan, Xu, Frey, Liu (bib0610) 2008; 9 Saccone, Lindsey, Koeppe, Zelenock, Shao, Sherman, Quesada, Woods, Scott (bib0790) 2016; 359 Wengst, Reichl (bib0935) 2010; 74 Kou, Yao, Sivaprakasam, Luo, Sun, Fu, He, Sun, Ganapathy (bib0540) 2017; 24 Sun, Shen, Wu, Chi, Yang, Yuan, Xie, Zhang, Chen, Zhang (bib0875) 2010; 2 Thakker, Shanbag (bib0885) 2013; 260 Dahlin, Jansson, Björk (bib0175) 2001; 14 Djupesland (bib0225) 2013; 3 Mahmoudian, Mohammad (bib0620) 2004; 5 Salameh, Bullock, Hujoel, Niehoff, Wolden-Hanson, Kim, Morley, Farr, Banks (bib0795) 2015; 47 Schreider (bib0815) 1983 Mizutani, Nabe, Takenaka, Kohno (bib0660) 2003; 93 Kou, Bhutia, Yao, He, Sun, Ganapathy (bib0535) 2018; 9 Montenegro, Campisi, Sarpietro, Carbone, Acquaviva, Raciti, Puglisi (bib0665) 2011; 37 Rat, Schmitt, Tippmann, Dewachter, Theunis, Wieczerzak, Postina, van Leuven, Fahrenholz, Kojro (bib0770) 2011; 25 Mistry, Stolnik, Illum (bib0650) 2009; 379 Leon (bib0575) 1998 Heinrichs, Baumgartner, Kirschbaum, Ehlert (bib0420) 2003; 54 Crowe, Greenlee, Kanthasamy, Hsu (bib0165) 2018; 195 Bhavna, Md, Ali, Ali, Bhatnagar, Baboota, Ali (bib0080) 2014; 67 Gizurarson, Gudbrandsson, Jónsson, Bechgaard (bib0325) 1999; 22 Kublik, Vidgren (bib0550) 1998; 29 Hosoya, Kubo, Natsume, Sugibayashi, Morimoto (bib0440) 1994; 17 Nakamura, Ohta, Machida, Nagai (bib0695) 1996; 134 During, Cao, Zuzga, Francis, Fitzsimons, Jiao, Bland, Klugmann, Banks, Drucker, Haile (bib0255) 2003; 9 Werner, Kissel (bib0945) 1995; 12 Pardeshi, Rajput, Belgamwar, Tekade, Surana (bib0730) 2013; 20 Gorbatov, Trekova, Fomina, Davydova (bib0335) 2010; 150 Schiöth, Craft, Brooks, Frey, Benedict (bib0805) 2012; 46 Claxton, Baker, Wilkinson, Trittschuh, Chapman, Watson, Cholerton, Plymate, Arbuckle, Craft (bib0140) 2013; 35 Pacifici (bib0720) 2014; 2014 Domes, Heinrichs, Michel, Berger, Herpertz (bib0240) 2007; 61 Qian, He, Wang, Wong, Mak, Ho, Han, Zuo (bib0760) 2018; 207 Vig, Subramony, D’Souza, Wei, Lopez (bib0900) 2006; 69 Kamiya, Yamaki, Omori, Uchida, Ohtake, Kimura, Yamazaki, Natsume (bib0480) 2018; 11 Hallschmid, Smolnik, McGregor, Born, Fehm (bib0400) 2006; 91 Sharma, Maheshwari, Philip, Rana, Bhatia, Singh, Gabrani, Sharma, Ali, Sharma, Dang (bib0830) 2014; 2014 Derad, Sayk, Lehnert, Marshall, Born, Nitschke (bib0205) 2014; 63 Benedict, Kern, Schultes, Born, Hallschmid (bib0070) 2008; 93 Illum (bib0455) 2000; 11 Xu, Liu, Yang, Liu, Wang, Cheng, Cheng (bib0965) 2009; 461 Khan, Liu, Khan, Zhai (bib0510) 2017; 268 Mygind, Dahl (bib0685) 1998; 29 Sonvico, Clementino, Buttini, Colombo, Pescina, Guterres, Pohlmann, Nicoli (bib0860) 2018; 10 Derad, Willeke, Pietrowsky, Born, Fehm (bib0210) 1998; 11 Ross, Martinez, Renner, Thorne, Hanson, Frey (bib0785) 2004; 151 Chapman, Frey, Craft, Danielyan, Hallschmid, Schiöth, Benedict (bib0110) 2013; 30 Deadwyler, Porrino, Siegel, Hampson (bib0195) 2007; 27 Fişgin, Gurer, Tezic, Senbil, Zorlu, Okuyaz, Akgün (bib0285) 2002; 17 De Rosa, Garcia, Braschi, Capsoni, Maffei, Berardi, Cattaneo (bib0190) 2005; 102 Mistry, Stolnik, Illum (bib0645) 2015; 12 Merkus, Verhoef, Schipper, Marttin (bib0635) 1998; 29 Md, Haque, Fazil, Kumar, Baboota, Sahni, Ali (bib0630) 2014; 11 Henney, Sperling, Rabinowicz, Bream, Carrazana (bib0425) 2014; 108 Agarwal, Kriel, Brundage, Ivaturi, Cloyd (bib0005) 2013; 105 Barakat, Omar, Ahmed (bib0045) 2006; 58 Cho, Termsarasab, Kim (bib0135) 2010; 40 Digicaylioglu, Garden, Timberlake, Fletcher, Lipton (bib0220) 2004; 101 Gao, Wu, Zhang, Chen, Zhu, Zhang, Rong, Chen, Jiang (bib0300) 2007; 121 Ivaturi, Kriel, Brundage, Loewen, Mansbach, Cloyd (bib0460) 2013; 103 Westin, Piras, Jansson, Bergström, Dahlin, Brittebo, Björk (bib0950) 2005; 24 Gonçalves, Matias, Poejo, Serra, Duarte (bib0330) 2016; 515 Clerico, To, Lanza (bib0145) 2003 Tan, Trier, Rahbek, Dufva, Kutter, Andresen (bib0880) 2018; 13 Wang, Jiang, Lu (bib0910) 2003; 263 Gordon, Moses, Silver, Flier, Carey (bib0340) 1985; 82 Gizurarson (bib0315) 2012; 9 Graff, Pollack (bib0365) 2003; 20 Schmidt, Hagen, Steffen, Günter, Hans (bib0810) 1998; 29 Yang, Liu, Cheng, Wang, Cheng, Yu, Liu (bib0975) 2009; 449 Craft, Baker, Montine, Minoshima, Watson, Claxton, Arbuckle, Callaghan, Tsai, Plymate, Green, Leverenz, Cross, Gerton (bib0155) 2012; 69 Patel, Chavhan, Soni, Babbar, Mathur, Mishra, Sawant (bib0740) 2011; 19 Watelet, Van Cauwenberge (bib0930) 1998; 54 Dolberg, Reichl (bib0235) 2016; 508 Wang, He, Leng, Tang (bib0915) 2006; 317 Consonni, Sharma, Schön, Lebrero-Fernández, Rinaldi, Lycke, Baggi (bib0150) 2017; 8 Graff, Zhao, Pollack (bib0370) 2005; 22 Reger, Watson, Frey, Baker, Cholerton, Keeling, Belongia, Fishel, Plymate, Schellenberg, Cherrier, Craft (bib0775) 2006; 27 Mygind, Änggård (bib0680) 1984; 2 Fehm, Smolnik, Kern, McGregor, Bickel, Born (bib0280) 2001; 86 Krasnow, Fraley, Schuh, Baumgartner, Clifton, Steiner (bib0545) 2003; 144 Born, Lange, Kern, McGregor, Bickel, Fehm (bib0090) 2002; 5 Chao, Mattern, De Souza Silva, Weßler, Ruocco, Nikolaus, Huston, Pum (bib0105) 2012; 87 Dhuria, Hanson, Frey (bib0215) 2010; 99 Fliedner, Schulz, Lehnert (bib0295) 2006; 147 Hada, Netzer, Belhassan, Wennogle, Gizurarson (bib0395) 2017; 102 Chhajed, Sangale, Barhate (bib0130) 2011; 2 Bistritzer, Berkovitch, Lahat, Goldman, Barr (bib0085) 2000; 321 Singh, Bothara, Singh, Patel, Ughreja (bib0850) 2011; 5 Baier, Weinhold, Huth, Gottwald, Ferstl, Hinze-Selch (bib0025) 2008; 131 Wang, Cheng, Ma, Ma, Yang, Xu, Liu (bib0920) 2008; 446 Gozes (bib0345) 2011; 32 Kang, Park (bib0495) 2000; 23 Xu, Rensing, Yang, Hai, Liu, Rothman, Weisenfeld, Wong, Yamada (bib0970) 2008; 118 Giroux (bib0310) 2007 Charlton, Jones, Davis, Illum (bib0115) 2007; 30 Stevens, Suidgeest, Van Der Graaf, Danhof, De Lange (bib0865) 2009; 26 Moore, Smith, Greenlee, Nicholson, Richt, Greenlee (bib0675) 2016; 53 Gross, Swenberg, Fields, Popp (bib0380) 1982; 135 Wolburg, Wolburg-Buchholz, Sam, Horvát, Deli, Mack (bib0955) 2008; 130 Gartziandia, Egusquiaguirre, Bianco, Pedraz, Igartua, Hernandez, Préat, Beloqui (bib0305) 2016; 499 Lu, Du, Bai, Li, Wen, Zhao (bib0600) 2012; 13 Arora, Sharma, Garg (bib0015) 2002; 7 Culman, Baulmann, Blume, Unger (bib0170) 2001; 2 Olafsson, Gizurarson (bib0715) 2000; 27 Warnken, Smyth, Watts, Weitman, Kuhn, Williams (bib0925) 2016; 35 Espefält Westin (bib0265) 2007; 55 Hanson, Frey (bib0405) 2008; 9 Wermeling, Record, Kelly, Archer, Clinch, Rudy (bib0940) 2006; 103 Deli (bib0200) 2009 Chen, Fawcett, Rahman, Ala, Frey Hardy (10.1016/j.brainresbull.2018.10.009_bib0410) 1985; 37 Wang (10.1016/j.brainresbull.2018.10.009_bib0915) 2006; 317 Werner (10.1016/j.brainresbull.2018.10.009_bib0945) 1995; 12 Sato (10.1016/j.brainresbull.2018.10.009_bib0800) 2007; 7 Sun (10.1016/j.brainresbull.2018.10.009_bib0875) 2010; 2 Pardeshi (10.1016/j.brainresbull.2018.10.009_bib0730) 2013; 20 Khan (10.1016/j.brainresbull.2018.10.009_bib0515) 2009; 61 Mizutani (10.1016/j.brainresbull.2018.10.009_bib0660) 2003; 93 Kou (10.1016/j.brainresbull.2018.10.009_bib0540) 2017; 24 Gordon (10.1016/j.brainresbull.2018.10.009_bib0340) 1985; 82 Micieli (10.1016/j.brainresbull.2018.10.009_bib0640) 2017; 44 Smolnik (10.1016/j.brainresbull.2018.10.009_bib0855) 2000; 20 Benedict (10.1016/j.brainresbull.2018.10.009_bib0070) 2008; 93 Van Velthoven (10.1016/j.brainresbull.2018.10.009_bib0895) 2010; 68 Kang (10.1016/j.brainresbull.2018.10.009_bib0495) 2000; 23 Banks (10.1016/j.brainresbull.2018.10.009_bib0040) 2002; 302 Fazil (10.1016/j.brainresbull.2018.10.009_bib0270) 2012; 47 Crowe (10.1016/j.brainresbull.2018.10.009_bib0165) 2018; 195 Sonvico (10.1016/j.brainresbull.2018.10.009_bib0860) 2018; 10 Warnken (10.1016/j.brainresbull.2018.10.009_bib0925) 2016; 35 Graff (10.1016/j.brainresbull.2018.10.009_bib0355) 2005; 22 Graff (10.1016/j.brainresbull.2018.10.009_bib0360) 2004; 5 Mistry (10.1016/j.brainresbull.2018.10.009_bib0650) 2009; 379 Fliedner (10.1016/j.brainresbull.2018.10.009_bib0295) 2006; 147 Gozes (10.1016/j.brainresbull.2018.10.009_bib0350) 2000; 293 Kamiya (10.1016/j.brainresbull.2018.10.009_bib0480) 2018; 11 Craft (10.1016/j.brainresbull.2018.10.009_bib0155) 2012; 69 Polt (10.1016/j.brainresbull.2018.10.009_bib0750) 1994; 91 Derad (10.1016/j.brainresbull.2018.10.009_bib0210) 1998; 11 Tan (10.1016/j.brainresbull.2018.10.009_bib0880) 2018; 13 Banks (10.1016/j.brainresbull.2018.10.009_bib0030) 2004; 10 Schreider (10.1016/j.brainresbull.2018.10.009_bib0815) 1983 Pennington (10.1016/j.brainresbull.2018.10.009_bib0745) 1988; 43 Westin (10.1016/j.brainresbull.2018.10.009_bib0950) 2005; 24 Wang (10.1016/j.brainresbull.2018.10.009_bib0910) 2003; 263 Kandimalla (10.1016/j.brainresbull.2018.10.009_bib0485) 2005; 302 Xu (10.1016/j.brainresbull.2018.10.009_bib0965) 2009; 461 Djupesland (10.1016/j.brainresbull.2018.10.009_bib0230) 2012; 25 Proctor (10.1016/j.brainresbull.2018.10.009_bib0755) 1982 Dhuria (10.1016/j.brainresbull.2018.10.009_bib0215) 2010; 99 Gozes (10.1016/j.brainresbull.2018.10.009_bib0345) 2011; 32 Md (10.1016/j.brainresbull.2018.10.009_bib0630) 2014; 11 Arora (10.1016/j.brainresbull.2018.10.009_bib0015) 2002; 7 Domes (10.1016/j.brainresbull.2018.10.009_bib0240) 2007; 61 Wolburg (10.1016/j.brainresbull.2018.10.009_bib0955) 2008; 130 Hada (10.1016/j.brainresbull.2018.10.009_bib0395) 2017; 102 Hosoya (10.1016/j.brainresbull.2018.10.009_bib0440) 1994; 17 Heinrichs (10.1016/j.brainresbull.2018.10.009_bib0420) 2003; 54 Shahaf (10.1016/j.brainresbull.2018.10.009_bib0825) 2016 Craven (10.1016/j.brainresbull.2018.10.009_bib0160) 2007; 290 Li (10.1016/j.brainresbull.2018.10.009_bib0580) 2004; 3 Kern (10.1016/j.brainresbull.2018.10.009_bib0505) 1999; 48 Merkus (10.1016/j.brainresbull.2018.10.009_bib0635) 1998; 29 Watelet (10.1016/j.brainresbull.2018.10.009_bib0930) 1998; 54 Jogani (10.1016/j.brainresbull.2018.10.009_bib0470) 2008; 22 Pardeshi (10.1016/j.brainresbull.2018.10.009_bib0725) 2013; 10 Deadwyler (10.1016/j.brainresbull.2018.10.009_bib0195) 2007; 27 Claxton (10.1016/j.brainresbull.2018.10.009_bib0140) 2013; 35 Mygind (10.1016/j.brainresbull.2018.10.009_bib0680) 1984; 2 Kosfeld (10.1016/j.brainresbull.2018.10.009_bib0530) 2005; 435 Gross (10.1016/j.brainresbull.2018.10.009_bib0380) 1982; 135 Hoang (10.1016/j.brainresbull.2018.10.009_bib0430) 2002; 238 Fehm (10.1016/j.brainresbull.2018.10.009_bib0280) 2001; 86 Lungare (10.1016/j.brainresbull.2018.10.009_bib0605) 2016; 105 Ma (10.1016/j.brainresbull.2018.10.009_bib0610) 2008; 9 Kälviäinen (10.1016/j.brainresbull.2018.10.009_bib0475) 2015; 49 Chaturvedi (10.1016/j.brainresbull.2018.10.009_bib0120) 2011; 2 Laing (10.1016/j.brainresbull.2018.10.009_bib0565) 2006; 13 Pardridge (10.1016/j.brainresbull.2018.10.009_bib0735) 2005; 2 Mahmoudian (10.1016/j.brainresbull.2018.10.009_bib0620) 2004; 5 Kürti (10.1016/j.brainresbull.2018.10.009_bib0555) 2013; 50 Illum (10.1016/j.brainresbull.2018.10.009_bib0450) 2003; 87 Guillot (10.1016/j.brainresbull.2018.10.009_bib0390) 1991; 1 Gorbatov (10.1016/j.brainresbull.2018.10.009_bib0335) 2010; 150 Henney (10.1016/j.brainresbull.2018.10.009_bib0425) 2014; 108 Zhu (10.1016/j.brainresbull.2018.10.009_bib0980) 2011; 18 Schmidt (10.1016/j.brainresbull.2018.10.009_bib0810) 1998; 29 Sharma (10.1016/j.brainresbull.2018.10.009_bib0830) 2014; 2014 Rakover (10.1016/j.brainresbull.2018.10.009_bib0765) 2010; 225 Hanson (10.1016/j.brainresbull.2018.10.009_bib0405) 2008; 9 Moore (10.1016/j.brainresbull.2018.10.009_bib0675) 2016; 53 Consonni (10.1016/j.brainresbull.2018.10.009_bib0150) 2017; 8 Wang (10.1016/j.brainresbull.2018.10.009_bib0905) 2006; 57 De Rosa (10.1016/j.brainresbull.2018.10.009_bib0190) 2005; 102 Gartziandia (10.1016/j.brainresbull.2018.10.009_bib0305) 2016; 499 Baier (10.1016/j.brainresbull.2018.10.009_bib0025) 2008; 131 Salameh (10.1016/j.brainresbull.2018.10.009_bib0795) 2015; 47 De Haan (10.1016/j.brainresbull.2018.10.009_bib0185) 2010; 51 Chapman (10.1016/j.brainresbull.2018.10.009_bib0110) 2013; 30 Lochhead (10.1016/j.brainresbull.2018.10.009_bib0590) 2012; 64 Gizurarson (10.1016/j.brainresbull.2018.10.009_bib0315) 2012; 9 Nijboer (10.1016/j.brainresbull.2018.10.009_bib0705) 2018 Dolberg (10.1016/j.brainresbull.2018.10.009_bib0235) 2016; 508 Labuschagne (10.1016/j.brainresbull.2018.10.009_bib0560) 2010; 35 Bai (10.1016/j.brainresbull.2018.10.009_bib0020) 2008; 97 Sharma (10.1016/j.brainresbull.2018.10.009_bib0835) 2011; 32 Singh (10.1016/j.brainresbull.2018.10.009_bib0850) 2011; 5 Gizurarson (10.1016/j.brainresbull.2018.10.009_bib0325) 1999; 22 Wermeling (10.1016/j.brainresbull.2018.10.009_bib0940) 2006; 103 Xu (10.1016/j.brainresbull.2018.10.009_bib0970) 2008; 118 Romanova (10.1016/j.brainresbull.2018.10.009_bib0780) 2010; 149 Giroux (10.1016/j.brainresbull.2018.10.009_bib0310) 2007 Lu (10.1016/j.brainresbull.2018.10.009_bib0600) 2012; 13 Lei (10.1016/j.brainresbull.2018.10.009_bib0570) 2017; 134 Bates (10.1016/j.brainresbull.2018.10.009_bib0050) 2014 Bistritzer (10.1016/j.brainresbull.2018.10.009_bib0085) 2000; 321 Behl (10.1016/j.brainresbull.2018.10.009_bib0055) 1998; 29 Chhajed (10.1016/j.brainresbull.2018.10.009_bib0130) 2011; 2 Ma (10.1016/j.brainresbull.2018.10.009_bib0615) 2008; 437 Bhattacharyya (10.1016/j.brainresbull.2018.10.009_bib0075) 2006; 34 Hsuchou (10.1016/j.brainresbull.2018.10.009_bib0445) 2013; 51 Graff (10.1016/j.brainresbull.2018.10.009_bib0365) 2003; 20 Mistry (10.1016/j.brainresbull.2018.10.009_bib0645) 2015; 12 Agarwal (10.1016/j.brainresbull.2018.10.009_bib0005) 2013; 105 Dahlin (10.1016/j.brainresbull.2018.10.009_bib0175) 2001; 14 Mittal (10.1016/j.brainresbull.2018.10.009_bib0655) 2006; 73 Kou (10.1016/j.brainresbull.2018.10.009_bib0535) 2018; 9 Leon (10.1016/j.brainresbull.2018.10.009_bib0575) 1998 Lindup (10.1016/j.brainresbull.2018.10.009_bib0585) 1981; 282 Klingenberg (10.1016/j.brainresbull.2018.10.009_bib0525) 2010; 30 Wu (10.1016/j.brainresbull.2018.10.009_bib0960) 2008; 5 Cho (10.1016/j.brainresbull.2018.10.009_bib0135) 2010; 40 Digicaylioglu (10.1016/j.brainresbull.2018.10.009_bib0220) 2004; 101 Benedict (10.1016/j.brainresbull.2018.10.009_bib0060) 2011; 60 Krasnow (10.1016/j.brainresbull.2018.10.009_bib0545) 2003; 144 Nonaka (10.1016/j.brainresbull.2018.10.009_bib0710) 2008; 325 Mygind (10.1016/j.brainresbull.2018.10.009_bib0685) 1998; 29 Najafabadi (10.1016/j.brainresbull.2018.10.009_bib0690) 2004; 11 Culman (10.1016/j.brainresbull.2018.10.009_bib0170) 2001; 2 Khan (10.1016/j.brainresbull.2018.10.009_bib0510) 2017; 268 Touitou (10.1016/j.brainresbull.2018.10.009_bib0890) 2013; 3 Banks (10.1016/j.brainresbull.2018.10.009_bib0035) 1999; 20 Wengst (10.1016/j.brainresbull.2018.10.009_bib0935) 2010; 74 Bhavna (10.1016/j.brainresbull.2018.10.009_bib0080) 2014; 67 Ross (10.1016/j.brainresbull.2018.10.009_bib0785) 2004; 151 Deli (10.1016/j.brainresbull.2018.10.009_bib0200) 2009 Monti-Bloch (10.1016/j.brainresbull.2018.10.009_bib0670) 1998 Derad (10.1016/j.brainresbull.2018.10.009_bib0205) 2014; 63 Djupesland (10.1016/j.brainresbull.2018.10.009_bib0225) 2013; 3 Alcalay (10.1016/j.brainresbull.2018.10.009_bib0010) 2004; 361 Capsoni (10.1016/j.brainresbull.2018.10.009_bib0100) 2002; 99 Shiryaev (10.1016/j.brainresbull.2018.10.009_bib0840) 2009; 34 Benedict (10.1016/j.brainresbull.2018.10.009_bib0065) 2004; 29 Kublik (10.1016/j.brainresbull.2018.10.009_bib0550) 1998; 29 Olafsson (10.1016/j.brainresbull.2018.10.009_bib0715) 2000; 27 Pacifici (10.1016/j.brainresbull.2018.10.009_bib0720) 2014; 2014 Gray (10.1016/j.brainresbull.2018.10.009_bib0375) 1978 10.1016/j.brainresbull.2018.10.009_bib0700 Seju (10.1016/j.brainresbull.2018.10.009_bib0820) 2011; 7 Fehm (10.1016/j.brainresbull.2018.10.009_bib0275) 2000 Guastella (10.1016/j.brainresbull.2018.10.009_bib0385) 2010; 67 Gao (10.1016/j.brainresbull.2018.10.009_bib0300) 2007; 121 Montenegro (10.1016/j.brainresbull.2018.10.009_bib0665) 2011; 37 Gizurarson (10.1016/j.brainresbull.2018.10.009_bib0320) 1990; 2 During (10.1016/j.brainresbull.2018.10.009_bib0255) 2003; 9 Hashizume (10.1016/j.brainresbull.2018.10.009_bib0415) 2008; 10 Hallschmid (10.1016/j.brainresbull.2018.10.009_bib0400) 2006; 91 Streisand (10.1016/j.brainresbull.2018.10.009_bib0870) 1995; 6 Dalpiaz (10.1016/j.brainresbull.2018.10.009_bib0180) 2014; 11 Karasulu (10.1016/j.brainresbull.2018.10.009_bib0500) 2008; 15 Ivaturi (10.1016/j.brainresbull.2018.10.009_bib0460) 2013; 103 Saccone (10.1016/j.brainresbull.2018.10.009_bib0790) 2016; 359 Wang (10.1016/j.brainresbull.2018.10.009_bib0920) 2008; 446 Rat (10.1016/j.brainresbull.2018.10.009_bib0770) 2011; 25 Qian (10.1016/j.brainresbull.2018.10.009_bib0760) 2018; 207 Illum (10.1016/j.brainresbull.2018.10.009_bib0455) 2000; 11 Singh (10.1016/j.brainresbull |
| References_xml | – volume: 10 start-page: 1365 year: 2004 end-page: 1370 ident: bib0030 article-title: Are the extracelluar pathways a conduit for the delivery of therapeutics to the brain? publication-title: Curr. Pharm. Des. – volume: 147 start-page: 2088 year: 2006 end-page: 2094 ident: bib0295 article-title: Brain uptake of intranasally applied radioiodinated leptin in Wistar rats publication-title: Endocrinology – year: 2018 ident: bib0705 article-title: Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage publication-title: Stem Cells Dev. – volume: 195 start-page: 44 year: 2018 end-page: 52 ident: bib0165 article-title: Mechanism of intranasal drug delivery directly to the brain publication-title: Life Sci. – volume: 2014 start-page: 1 year: 2014 end-page: 20 ident: bib0720 article-title: Clinical pharmacology of midazolam in neonates and children: effect of disease—a review publication-title: Int. J. Pediatr. – start-page: 373 year: 1998 end-page: 389 ident: bib0670 article-title: The human vomeronasal system: a review publication-title: Ann. N. Y. Acad. Sci. – volume: 51 start-page: 478 year: 2010 end-page: 482 ident: bib0185 article-title: A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations publication-title: Epilepsia – volume: 64 start-page: 614 year: 2012 end-page: 628 ident: bib0590 article-title: Intranasal delivery of biologics to the central nervous system publication-title: Adv. Drug Deliv. Rev. – volume: 7 start-page: 967 year: 2002 end-page: 975 ident: bib0015 article-title: Permeability issues in nasal drug delivery publication-title: Drug Discov. Today – volume: 268 start-page: 364 year: 2017 end-page: 389 ident: bib0510 article-title: Progress in brain targeting drug delivery system by nasal route publication-title: J. Control. Release – volume: 69 start-page: 29 year: 2012 end-page: 38 ident: bib0155 article-title: Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial publication-title: Arch. Neurol. – volume: 317 start-page: 40 year: 2006 end-page: 46 ident: bib0915 article-title: Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method publication-title: Int. J. Pharm. – volume: 13 start-page: 14127 year: 2012 end-page: 14135 ident: bib0600 article-title: Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice publication-title: Int. J. Mol. Sci. – volume: 302 start-page: 133 year: 2005 end-page: 144 ident: bib0485 article-title: Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules publication-title: Int. J. Pharm. – reference: Nasal Cavity [WWW Document], 2017. Respir. Syst. URL – volume: 12 start-page: 565 year: 1995 end-page: 571 ident: bib0945 article-title: Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions publication-title: Pharm. Res. – volume: 437 start-page: 93 year: 2008 end-page: 97 ident: bib0615 article-title: Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia publication-title: Neurosci. Lett. – year: 1982 ident: bib0755 article-title: The Nose: Upper Airway Physiology and the Atmospheric Enviroment – volume: 67 start-page: 692 year: 2010 end-page: 694 ident: bib0385 article-title: Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders publication-title: Biol. Psychiatry – volume: 27 start-page: 451 year: 2006 end-page: 458 ident: bib0775 article-title: Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype publication-title: Neurobiol. Aging – volume: 149 start-page: 289 year: 2010 end-page: 292 ident: bib0780 article-title: Effect of antibodies to glutamate on retention of conditioned passive avoidance response in rats with ischemic injury of the prefrontal cortex publication-title: Bull. Exp. Biol. Med. – year: 2014 ident: bib0050 article-title: The Blood-Brain Barrier – volume: 51 start-page: 364 year: 2013 end-page: 370 ident: bib0445 article-title: Saturable leptin transport across the BBB persists in EAE mice publication-title: J. Mol. Neurosci. – volume: 103 start-page: 254 year: 2013 end-page: 261 ident: bib0460 article-title: Bioavailability of Intranasal vs. Rectal Diazepam publication-title: Epilepsy Res. – volume: 255 start-page: 87 year: 2003 end-page: 97 ident: bib0250 article-title: Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats publication-title: Int. J. Pharm. – year: 2007 ident: bib0310 article-title: Particle Dispersion Device for Nasal Delivery – volume: 87 start-page: 340 year: 2012 end-page: 345 ident: bib0105 article-title: Intranasally applied publication-title: Brain Res. Bull. – volume: 19 start-page: 468 year: 2011 end-page: 474 ident: bib0740 article-title: Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route publication-title: J. Drug Target. – volume: 2 start-page: 215 year: 2011 ident: bib0120 article-title: A review on mucoadhesive polymer used in nasal drug delivery system publication-title: J. Adv. Pharm. Technol. Res. – volume: 2 start-page: 1322 year: 2011 end-page: 1336 ident: bib0130 article-title: Advantageous nasal drug delivery system: a review publication-title: Int. J. Pharm. Sci. Res. – volume: 15 start-page: 219 year: 2008 end-page: 225 ident: bib0500 article-title: Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers publication-title: Drug Deliv. – volume: 102 start-page: 3811 year: 2005 end-page: 3816 ident: bib0190 article-title: Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 68 start-page: 342 year: 2010 end-page: 352 ident: bib0490 article-title: Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders publication-title: Ann. Neurol. – volume: 325 start-page: 513 year: 2008 end-page: 519 ident: bib0710 article-title: Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins publication-title: J. Pharmacol. Exp. Ther. – volume: 2 start-page: 173 year: 1984 end-page: 188 ident: bib0680 article-title: Anatomy and physiology of the nose-pathophysiologic alterations in allergic rhinitis publication-title: Clin. Rev. Allergy – volume: 321 start-page: 83 year: 2000 end-page: 86 ident: bib0085 article-title: Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study publication-title: BMJ – volume: 20 start-page: 47 year: 2013 end-page: 56 ident: bib0730 article-title: Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach publication-title: Drug Deliv. – volume: 34 start-page: 355 year: 2006 end-page: 359 ident: bib0075 article-title: Intranasal midazolam vs rectal diazepam in acute childhood seizures publication-title: Pediatr. Neurol. – volume: 99 start-page: 12432 year: 2002 end-page: 12437 ident: bib0100 article-title: Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 93 start-page: 1339 year: 2008 end-page: 1344 ident: bib0070 article-title: Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin publication-title: J. Clin. Endocrinol. Metab. – volume: 25 start-page: 3208 year: 2011 end-page: 3218 ident: bib0770 article-title: Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer’s disease-like pathology in amyloid precursor protein-transgenic mice publication-title: FASEB J. – volume: 34 start-page: 381 year: 2009 end-page: 388 ident: bib0840 article-title: NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model publication-title: Neurobiol. Dis. – volume: 54 start-page: 1389 year: 2003 end-page: 1398 ident: bib0420 article-title: Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress publication-title: Biol. Psychiatry – volume: 37 start-page: 737 year: 2011 end-page: 746 ident: bib0665 article-title: In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain publication-title: Drug Dev. Ind. Pharm. – year: 2016 ident: bib0825 article-title: Nasal Delivery Device – volume: 11 year: 2018 ident: bib0480 article-title: Improved intranasal retentivity and transnasal absorption enhancement by PEGylated poly-L-ornithine publication-title: Pharmaceuticals – volume: 10 year: 2018 ident: bib0860 article-title: Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting publication-title: Pharmaceutics – volume: 108 start-page: 1204 year: 2014 end-page: 1211 ident: bib0425 article-title: Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults publication-title: Epilepsy Res. – volume: 359 start-page: 366 year: 2016 end-page: 373 ident: bib0790 article-title: Intranasal opioid administration in Rhesus monkeys: PET imaging and antinociception publication-title: J. Pharmacol. Exp. Ther. – volume: 13 start-page: 870 year: 2006 end-page: 881 ident: bib0565 article-title: Intranasal administration of the growth-compromised HSV-2 vector ΔRR prevents kainate-induced seizures and neuronal loss in rats and mice publication-title: Mol. Ther. – year: 2003 ident: bib0145 article-title: Anatomy of the human nasal passages publication-title: Handbook of Olfaction and Gustation – volume: 9 year: 2008 ident: bib0405 article-title: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease publication-title: BMC Neurosci. – volume: 58 start-page: 63 year: 2006 end-page: 72 ident: bib0045 article-title: Carbamazepine uptake into rat brain following intra-olfactory transport publication-title: J. Pharm. Pharmacol. – volume: 3 start-page: 42 year: 2013 end-page: 62 ident: bib0225 article-title: Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review publication-title: Drug Deliv. Transl. Res. – volume: 27 year: 2000 ident: bib0715 article-title: Access to the olfactory region publication-title: Proc. Control. Release Bioact. Mater. – volume: 17 start-page: 123 year: 2002 end-page: 126 ident: bib0285 article-title: Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study publication-title: J. Child Neurol. – volume: 29 start-page: 3 year: 1998 end-page: 12 ident: bib0685 article-title: Anatomy, physiology and function of the nasal cavities in health and disease publication-title: Adv. Drug Deliv. Rev. – volume: 47 start-page: 6 year: 2012 end-page: 15 ident: bib0270 article-title: Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting publication-title: Eur. J. Pharm. Sci. – volume: 461 start-page: 212 year: 2009 end-page: 216 ident: bib0965 article-title: The doseeffectiveness of intranasal VEGF in treatment of experimental stroke publication-title: Neurosci. Lett. – volume: 2014 year: 2014 ident: bib0830 article-title: Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation publication-title: Biomed Res. Int. – volume: 73 start-page: 975 year: 2006 end-page: 978 ident: bib0655 article-title: Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures publication-title: Indian J. Pediatr. – volume: 22 start-page: 425 year: 1999 end-page: 427 ident: bib0325 article-title: Intranasal administration of diazepam aiming at the treatment of acute seizures: clinical trials in healthy volunteers publication-title: Biol. Pharm. Bull. – volume: 11 start-page: 827 year: 2014 end-page: 842 ident: bib0630 article-title: Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method publication-title: Expert Opin. Drug Deliv. – volume: 55 start-page: 64 year: 2007 ident: bib0265 article-title: Olfactory transfer of analgesic drugs after nasal administration publication-title: Digit. Compr. Summ. Uppsala Diss. from Fac. Pharm. – volume: 82 start-page: 7419 year: 1985 end-page: 7423 ident: bib0340 article-title: Nasal absorption of insulin: enhancement by hydrophobic bile salts publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 22 start-page: 116 year: 2008 end-page: 124 ident: bib0470 article-title: Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting publication-title: Alzheimer Dis. Assoc. Disord. – volume: 25 start-page: 11489 year: 2005 end-page: 11493 ident: bib0520 article-title: Oxytocin modulates neural circuitry for social cognition and fear in humans publication-title: J. Neurosci. – year: 1983 ident: bib0815 article-title: Nasal airway anatomy and inhalation deposition in experimental animals and people publication-title: Nasal Tumors in Animals and Man – volume: 130 start-page: 127 year: 2008 end-page: 140 ident: bib0955 article-title: Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat publication-title: Histochem. Cell Biol. – volume: 68 start-page: 419 year: 2010 end-page: 422 ident: bib0895 article-title: Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage publication-title: Pediatr. Res. – volume: 99 start-page: 1654 year: 2010 end-page: 1673 ident: bib0215 article-title: Intranasal delivery to the central nervous system: mechanisms and experimental considerations publication-title: J. Pharm. Sci. – volume: 22 start-page: 86 year: 2005 end-page: 93 ident: bib0355 article-title: Functional evidence for P-glycoprotein at the nose-brain barrier publication-title: Pharm. Res. – volume: 61 start-page: 731 year: 2007 end-page: 733 ident: bib0240 article-title: Oxytocin improves “Mind-Reading” in humans publication-title: Biol. Psychiatry – volume: 3 start-page: 267 year: 2006 end-page: 273 ident: bib0465 article-title: Applications of microemulsion based drug delivery system publication-title: Curr. Drug Deliv. – volume: 27 start-page: 14239 year: 2007 end-page: 14247 ident: bib0195 article-title: Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates publication-title: J. Neurosci. – volume: 207 start-page: 428 year: 2018 end-page: 435 ident: bib0760 article-title: Intranasal delivery of a novel acetylcholinesterase inhibitor HLS-3 for treatment of Alzheimer’s disease publication-title: Life Sci. – volume: 3 start-page: 1 year: 2013 end-page: 3 ident: bib0890 article-title: Nasal drug delivery publication-title: Drug Deliv. Transl. Res. – volume: 135 start-page: 83 year: 1982 end-page: 88 ident: bib0380 article-title: Comparative morphometry of the nasal cavity in rats and mice publication-title: J. Anat. – volume: 164 start-page: 747 year: 2010 end-page: 753 ident: bib0435 article-title: Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy publication-title: Arch. Pediatr. Adolesc. Med. – volume: 61 start-page: 669 year: 2009 end-page: 675 ident: bib0515 article-title: Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats publication-title: J. Pharm. Pharmacol. – volume: 9 start-page: 335 year: 1992 end-page: 340 ident: bib0245 article-title: Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects publication-title: Diabet. Med. – volume: 9 start-page: 1173 year: 2003 end-page: 1179 ident: bib0255 article-title: Glucagon-like peptide-1 receptor is involved in learning and neuroprotection publication-title: Nat. Med. – volume: 7 start-page: 4169 year: 2011 end-page: 4176 ident: bib0820 article-title: Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies publication-title: Acta Biomater. – volume: 9 start-page: 2241 year: 2014 end-page: 2257 ident: bib0595 article-title: Current approaches to enhance CNS delivery of drugs across the brain barriers publication-title: Int. J. Nanomedicine – volume: 48 start-page: 557 year: 1999 end-page: 563 ident: bib0505 article-title: Central nervous system effects of intranasally administered insulin during euglycemia in men publication-title: Diabetes – volume: 302 start-page: 1062 year: 2002 end-page: 1069 ident: bib0040 article-title: Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse publication-title: J. Pharmacol. Exp. Ther. – volume: 101 start-page: 9855 year: 2004 end-page: 9860 ident: bib0220 article-title: Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 30 start-page: 295 year: 2007 end-page: 302 ident: bib0115 article-title: Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device publication-title: Eur. J. Pharm. Sci. – volume: 11 start-page: 295 year: 2004 end-page: 300 ident: bib0690 article-title: Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits publication-title: Drug Deliv. J. Deliv. Target. Ther. Agents – volume: 515 start-page: 1 year: 2016 end-page: 10 ident: bib0330 article-title: Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs publication-title: Int. J. Pharm. – volume: 103 start-page: 344 year: 2006 end-page: 349 ident: bib0940 article-title: Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers publication-title: Anesth. Analg. – volume: 14 start-page: 75 year: 2001 end-page: 80 ident: bib0175 article-title: Levels of dopamine in blood and brain following nasal administration to rats publication-title: Eur. J. Pharm. Sci. – volume: 91 start-page: 7114 year: 1994 end-page: 7118 ident: bib0750 article-title: Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier publication-title: Proc. Natl. Acad. Sci. U. S. A. – year: 2009 ident: bib0200 article-title: Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery publication-title: Biochim. Biophys. Acta Biomembr. – reference: . – volume: 29 start-page: 1326 year: 2004 end-page: 1334 ident: bib0065 article-title: Intranasal insulin improves memory in humans publication-title: Psychoneuroendocrinology – volume: 1 start-page: 35 year: 1998 end-page: 44 ident: bib0125 article-title: Delivery of nerve growth factor to the brain via the olfactory pathway publication-title: J. Alzheimer’s Dis. – volume: 17 start-page: 316 year: 1994 end-page: 322 ident: bib0440 article-title: Evaluation of enhancers to increase nasal absorption using Ussing chamber technique publication-title: Biol. Pharm. Bull. – volume: 87 start-page: 187 year: 2003 end-page: 198 ident: bib0450 article-title: Nasal drug delivery--possibilities, problems and solutions publication-title: J. Control. Release – volume: 13 year: 2018 ident: bib0880 article-title: A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies publication-title: PLoS One – volume: 44 start-page: 1400 year: 2017 end-page: 1401 ident: bib0640 article-title: Intranasal fentanyl for acute severe pain episodes control in a dog publication-title: Vet. Anaesth. Analg. – volume: 30 start-page: 2475 year: 2013 end-page: 2484 ident: bib0110 article-title: Intranasal treatment of central nervous system dysfunction in humans publication-title: Pharm. Res. – volume: 6 start-page: 1562 year: 2014 end-page: 1570 ident: bib0625 article-title: Design, Development and evaluation studies of buccal adhesive diltiazem tablets using natural edible mucoadhesives publication-title: Int. J. Pharmtech Res. – volume: 379 start-page: 146 year: 2009 end-page: 157 ident: bib0650 article-title: Nanoparticles for direct nose-to-brain delivery of drugs publication-title: Int. J. Pharm. – volume: 53 start-page: 1187 year: 2016 end-page: 1196 ident: bib0675 article-title: Comparison of two US sheep scrapie isolates supports identification as separate strains publication-title: Vet. Pathol. – volume: 2 start-page: 3 year: 2005 end-page: 14 ident: bib0735 article-title: The blood-brain barrier: bottleneck in brain drug development publication-title: NeuroRx – volume: 24 start-page: 565 year: 2005 end-page: 573 ident: bib0950 article-title: Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents publication-title: Eur. J. Pharm. Sci. – start-page: 43 year: 2000 end-page: 54 ident: bib0275 article-title: Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? publication-title: Eur. J. Pharmacol. – volume: 91 start-page: 522 year: 2006 end-page: 525 ident: bib0400 article-title: Brief report: overweight humans are resistant to the weight-reducing effects of melanocortin4-10 publication-title: J. Clin. Endocrinol. Metab. – volume: 24 start-page: 1338 year: 2017 end-page: 1349 ident: bib0540 article-title: Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy publication-title: Drug Deliv. – volume: 499 start-page: 81 year: 2016 end-page: 89 ident: bib0305 article-title: Nanoparticle transport across in vitro olfactory cell monolayers publication-title: Int. J. Pharm. – volume: 9 start-page: 566 year: 2012 end-page: 582 ident: bib0315 article-title: Anatomical and histological factors affecting intranasal drug and vaccine delivery publication-title: Curr. Drug Deliv. – volume: 446 start-page: 30 year: 2008 end-page: 35 ident: bib0920 article-title: Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia publication-title: Neurosci. Lett. – volume: 10 start-page: 112 year: 2008 end-page: 120 ident: bib0415 article-title: New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163 publication-title: Neuro. Oncol. – volume: 49 start-page: 303 year: 2015 end-page: 306 ident: bib0475 article-title: Intranasal therapies for acute seizures publication-title: Epilepsy Behav. – volume: 238 start-page: 247 year: 2002 end-page: 256 ident: bib0430 article-title: Characterization of human nasal primary culture systems to investigate peptide metabolism publication-title: Int. J. Pharm. – volume: 5 start-page: 253 year: 2004 end-page: 255 ident: bib0620 article-title: Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children publication-title: Epilepsy Behav. – volume: 435 start-page: 673 year: 2005 end-page: 676 ident: bib0530 article-title: Oxytocin increases trust in humans publication-title: Nature – volume: 290 start-page: 1325 year: 2007 end-page: 1340 ident: bib0160 article-title: Reconstruction and morphometric analysis of the nasal airway of the dog (Canis familiaris) and implications regarding olfactory airflo publication-title: Anat. Rec. – volume: 5 start-page: 95 year: 2004 end-page: 108 ident: bib0360 article-title: Drug transport at the blood-brain barrier and the choroid plexus publication-title: Curr. Drug Metab. – volume: 20 start-page: 1341 year: 1999 end-page: 1345 ident: bib0035 article-title: Impaired transport of leptin across the blood-brain barrier in obesity publication-title: Peptides – volume: 361 start-page: 128 year: 2004 end-page: 131 ident: bib0010 article-title: Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze publication-title: Neurosci. Lett. – volume: 20 start-page: 445 year: 2000 end-page: 454 ident: bib0855 article-title: Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone publication-title: J. Clin. Psychopharmacol. – volume: 50 start-page: 86 year: 2013 end-page: 92 ident: bib0555 article-title: In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration publication-title: Eur. J. Pharm. Sci. – volume: 20 start-page: 1225 year: 2003 end-page: 1230 ident: bib0365 article-title: P-glycoprotein attenuates brain uptake of substrates after nasal instillation publication-title: Pharm. Res. – volume: 2 start-page: 96 year: 2001 end-page: 102 ident: bib0170 article-title: The renin–angiotensin system in the brain: an update publication-title: J. Renin Angiotensin Aldosterone Syst. – volume: 93 year: 2003 ident: bib0660 article-title: Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig publication-title: J. Pharmacol. Sci. – volume: 6 start-page: 113 year: 1995 end-page: 120 ident: bib0870 article-title: Newer drug delivery systems publication-title: Curr. Anaesth. Crit. Care – volume: 10 start-page: 957 year: 2013 end-page: 972 ident: bib0725 article-title: Direct nose to brain drug delivery publication-title: Expert Opin. Drug Deliv. – volume: 32 start-page: 428 year: 2011 end-page: 431 ident: bib0345 article-title: Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate publication-title: Peptides – volume: 102 start-page: 46 year: 2017 end-page: 54 ident: bib0395 article-title: Nose-to-brain transport of imatinib mesylate: a pharmacokinetic evaluation publication-title: Eur. J. Pharm. Sci. – volume: 46 start-page: 4 year: 2012 end-page: 10 ident: bib0805 article-title: Brain insulin signaling and Alzheimer’s disease: current evidence and future directions publication-title: Mol. Neurobiol. – volume: 67 start-page: 418 year: 2014 end-page: 425 ident: bib0080 article-title: Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation publication-title: Int. J. Biol. Macromol. – volume: 11 start-page: 1550 year: 2014 end-page: 1561 ident: bib0180 article-title: Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles publication-title: Mol. Pharm. – volume: 29 start-page: 13 year: 1998 end-page: 38 ident: bib0635 article-title: Nasal mucociliary clearance as a factor in nasal drug delivery publication-title: Adv. Drug Deliv. Rev. – volume: 29 start-page: 157 year: 1998 end-page: 177 ident: bib0550 article-title: Nasal delivery systems and their effect on deposition and absorption publication-title: Adv. Drug Deliv. Rev. – volume: 43 start-page: 221 year: 1988 end-page: 224 ident: bib0745 article-title: The influence of solution viscosity on nasal spray deposition and clearance publication-title: Int. J. Pharm. – volume: 25 start-page: 280 year: 2012 end-page: 289 ident: bib0230 article-title: Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump publication-title: J. Aerosol Med. Pulm. Drug Deliv. – volume: 282 start-page: 212 year: 1981 end-page: 214 ident: bib0585 article-title: Clinical pharmacology: plasma protein binding of drugs publication-title: Br. Med. J. – volume: 118 start-page: 272 year: 2008 end-page: 280 ident: bib0970 article-title: Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents publication-title: J. Clin. Invest. – volume: 144 start-page: 813 year: 2003 end-page: 822 ident: bib0545 article-title: A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse publication-title: Endocrinology – start-page: 104 year: 1998 end-page: 108 ident: bib0575 article-title: Compensatory responses to early olfactory restriction publication-title: Ann. New York Acad. Sci. – volume: 40 start-page: 321 year: 2010 end-page: 332 ident: bib0135 article-title: In vitro nasal cell culture systems for drug transport studies publication-title: J. Pharm. Investig. – volume: 30 start-page: 946 year: 2010 end-page: 952 ident: bib0525 article-title: Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 82 start-page: 937 year: 1995 end-page: 948 ident: bib0095 article-title: SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat publication-title: Cell – volume: 5 start-page: 1159 year: 2008 end-page: 1168 ident: bib0960 article-title: From nose to brain: understanding transport capacity and transport rate of drugs publication-title: Expert Opin. Drug Deliv. – volume: 18 start-page: 338 year: 2011 end-page: 343 ident: bib0980 article-title: Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia publication-title: Drug Deliv. – volume: 29 start-page: 640 year: 2009 end-page: 647 ident: bib0290 article-title: Angiotensin II modulates BBB permeability via activation of the AT 1 receptor in brain endothelial cells publication-title: J. Cereb. Blood Flow Metab. – volume: 35 start-page: 213 year: 2016 end-page: 222 ident: bib0925 article-title: Formulation and device design to increase nose to brain drug delivery publication-title: J. Drug Deliv. Sci. Technol. – volume: 2 start-page: 105 year: 1990 end-page: 122 ident: bib0320 article-title: Animal models for intranasal drug delivery studies. A review article publication-title: Acta Pharm. Nord. – volume: 150 start-page: 23 year: 2010 end-page: 25 ident: bib0335 article-title: Antiamnestic effects of antibodies to glutamate in experimental alzheimer’s disease publication-title: Bull. Exp. Biol. Med. – volume: 5 start-page: 213 year: 2011 end-page: 220 ident: bib0850 article-title: Preliminary pharmaceutical characterization of some flowers as natural indicator publication-title: Pharma Res. – volume: 293 start-page: 1091 year: 2000 end-page: 1098 ident: bib0350 article-title: Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze publication-title: J. Pharmacol. Exp. Ther. – volume: 8 year: 2017 ident: bib0150 article-title: A novel approach to reinstating tolerance in experimental autoimmune myasthenia gravis using a targeted fusion protein, mCTA1-T146 publication-title: Front. Immunol. – volume: 29 start-page: 51 year: 1998 end-page: 79 ident: bib0810 article-title: In vitro cell models to study nasal mucosal permeability and metabolism publication-title: Adv. Drug Deliv. Rev. – year: 1978 ident: bib0375 article-title: Gray’s Anatomy – volume: 508 start-page: 22 year: 2016 end-page: 33 ident: bib0235 article-title: Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells publication-title: Int. J. Pharm. – volume: 105 start-page: 1209 year: 2016 end-page: 1220 ident: bib0605 article-title: Development and evaluation of a novel intranasal spray for the delivery of amantadine publication-title: J. Pharm. Sci. – volume: 29 start-page: 117 year: 1998 end-page: 133 ident: bib0055 article-title: Optimization of systemic nasal drug delivery with pharmaceutical excipients publication-title: Adv. Drug Deliv. Rev. – volume: 134 start-page: 173 year: 1996 end-page: 181 ident: bib0695 article-title: In vitro and in vivo nasal mucoadhesion of some water-soluble polymers publication-title: Int. J. Pharm. – volume: 47 start-page: 715 year: 2015 end-page: 728 ident: bib0795 article-title: Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition publication-title: J. Alzheimers Dis. – volume: 5 start-page: 514 year: 2002 end-page: 516 ident: bib0090 article-title: Sniffing neuropeptides: a transnasal approach to the human brain publication-title: Nat. Neurosci. – volume: 134 start-page: 79 year: 2017 end-page: 84 ident: bib0570 article-title: Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy publication-title: Brain Res. Bull. – volume: 69 start-page: 573 year: 2006 end-page: 579 ident: bib0900 article-title: Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice publication-title: Brain Res. Bull. – volume: 22 start-page: 235 year: 2005 end-page: 244 ident: bib0370 article-title: Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation publication-title: Pharm. Res. – volume: 449 start-page: 108 year: 2009 end-page: 111 ident: bib0975 article-title: Direct transport of VEGF from the nasal cavity to brain publication-title: Neurosci. Lett. – volume: 23 start-page: 391 year: 2000 end-page: 395 ident: bib0495 article-title: Brain uptake and the analgesic effect of oxytocin--its usefulness as an analgesic agent publication-title: Arch. Pharm. Res. – volume: 37 start-page: 294 year: 1985 end-page: 297 ident: bib0410 article-title: Intranasal drug delivery by spray and drops publication-title: J. Pharm. Pharmacol. – volume: 11 start-page: 1 year: 2000 end-page: 18 ident: bib0455 article-title: Transport of drugs from the nasal cavity to the central nervous system publication-title: Eur. J. Pharm. Sci. – volume: 8 start-page: 208 year: 2016 end-page: 215 ident: bib0845 article-title: Nano formulation: a novel approach for nose to brain drug delivery publication-title: J. Chem. Pharm. Res. – volume: 105 start-page: 362 year: 2013 end-page: 367 ident: bib0005 article-title: A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers publication-title: Epilepsy Res. – volume: 26 start-page: 1911 year: 2009 end-page: 1917 ident: bib0865 article-title: A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs publication-title: Pharm. Res. – volume: 151 start-page: 66 year: 2004 end-page: 77 ident: bib0785 article-title: Intranasal administration of interferon β bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis publication-title: J. Neuroimmunol. – volume: 11 start-page: 971 year: 1998 end-page: 977 ident: bib0210 article-title: Intranasal angiotensin II directly influences central nervous regulation of blood pressure publication-title: Am. J. Hypertens. – volume: 19 start-page: 998 year: 2002 end-page: 1008 ident: bib0260 article-title: Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles publication-title: Pharm. Res. – volume: 12 start-page: 2755 year: 2015 end-page: 2766 ident: bib0645 article-title: Nose-to-Brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium publication-title: Mol. Pharm. – volume: 63 start-page: 762 year: 2014 end-page: 767 ident: bib0205 article-title: Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked publication-title: Hypertension – volume: 1 start-page: 212 year: 1991 end-page: 218 ident: bib0390 article-title: Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability publication-title: J. Cardiovasc. Pharmacol. – volume: 35 start-page: 789 year: 2013 end-page: 797 ident: bib0140 article-title: Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease publication-title: J. Alzheimers Dis. – volume: 260 start-page: 470 year: 2013 end-page: 474 ident: bib0885 article-title: A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures publication-title: J. Neurol. – volume: 35 start-page: 2403 year: 2010 end-page: 2413 ident: bib0560 article-title: Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder publication-title: Neuropsychopharmacology – volume: 121 start-page: 156 year: 2007 end-page: 167 ident: bib0300 article-title: Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration publication-title: J. Control. Release – volume: 54 start-page: 14 year: 1998 end-page: 25 ident: bib0930 article-title: Applied anatomy and physiology of the nose and paranasal sinuses publication-title: Allergy – volume: 60 start-page: 114 year: 2011 end-page: 118 ident: bib0060 article-title: Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men publication-title: Diabetes – volume: 7 year: 2007 ident: bib0800 article-title: Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa publication-title: BMC Pharmacol. – volume: 32 start-page: 1217 year: 2011 end-page: 1224 ident: bib0835 article-title: Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain publication-title: Peptides – volume: 97 start-page: 1165 year: 2008 end-page: 1178 ident: bib0020 article-title: Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies publication-title: J. Pharm. Sci. – volume: 3 start-page: 123 year: 2004 end-page: 126 ident: bib0580 article-title: Transepithelial electrical measurements with the Ussing chamber publication-title: J. Cyst. Fibros. – volume: 263 start-page: 1 year: 2003 end-page: 7 ident: bib0910 article-title: Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats publication-title: Int. J. Pharm. – volume: 9 year: 2008 ident: bib0610 article-title: Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone publication-title: BMC Neurosci. – volume: 57 start-page: 97 year: 2006 end-page: 104 ident: bib0905 article-title: Study on brain targeting of raltitrexed following intranasal administration in rats publication-title: Cancer Chemother. Pharmacol. – volume: 225 start-page: 68 year: 2010 end-page: 76 ident: bib0765 article-title: Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope publication-title: J. Neuroimmunol. – volume: 2 start-page: 1502 year: 2010 end-page: 1513 ident: bib0875 article-title: Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats publication-title: Front Biosci (Elite Ed) – volume: 74 start-page: 290 year: 2010 end-page: 297 ident: bib0935 article-title: RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies publication-title: Eur. J. Pharm. Biopharm. – volume: 131 start-page: 2734 year: 2008 end-page: 2741 ident: bib0025 article-title: Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (hypocretin-1) publication-title: Brain – volume: 86 start-page: 1144 year: 2001 end-page: 1148 ident: bib0280 article-title: The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4–10) decreases body fat in humans publication-title: J. Clin. Endocrinol. Metabol. – volume: 9 year: 2018 ident: bib0535 article-title: Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types publication-title: Front. Pharmacol. – volume: 118 start-page: 272 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0970 article-title: Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents publication-title: J. Clin. Invest. doi: 10.1172/JCI33009 – volume: 149 start-page: 289 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0780 article-title: Effect of antibodies to glutamate on retention of conditioned passive avoidance response in rats with ischemic injury of the prefrontal cortex publication-title: Bull. Exp. Biol. Med. doi: 10.1007/s10517-010-0929-9 – volume: 6 start-page: 113 year: 1995 ident: 10.1016/j.brainresbull.2018.10.009_bib0870 article-title: Newer drug delivery systems publication-title: Curr. Anaesth. Crit. Care – volume: 40 start-page: 321 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0135 article-title: In vitro nasal cell culture systems for drug transport studies publication-title: J. Pharm. Investig. doi: 10.4333/KPS.2010.40.6.321 – volume: 67 start-page: 418 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0080 article-title: Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2014.03.022 – volume: 8 start-page: 208 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0845 article-title: Nano formulation: a novel approach for nose to brain drug delivery publication-title: J. Chem. Pharm. Res. – volume: 1 start-page: 212 issue: 18 year: 1991 ident: 10.1016/j.brainresbull.2018.10.009_bib0390 article-title: Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability publication-title: J. Cardiovasc. Pharmacol. doi: 10.1097/00005344-199108000-00006 – volume: 99 start-page: 12432 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0100 article-title: Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.192442999 – year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0200 article-title: Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery publication-title: Biochim. Biophys. Acta Biomembr. doi: 10.1016/j.bbamem.2008.09.016 – volume: 103 start-page: 344 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0940 article-title: Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers publication-title: Anesth. Analg. doi: 10.1213/01.ane.0000226150.90317.16 – volume: 82 start-page: 7419 year: 1985 ident: 10.1016/j.brainresbull.2018.10.009_bib0340 article-title: Nasal absorption of insulin: enhancement by hydrophobic bile salts publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.82.21.7419 – volume: 225 start-page: 68 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0765 article-title: Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2010.04.014 – volume: 19 start-page: 468 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0740 article-title: Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route publication-title: J. Drug Target. doi: 10.3109/1061186X.2010.523787 – volume: 9 start-page: 335 year: 1992 ident: 10.1016/j.brainresbull.2018.10.009_bib0245 article-title: Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects publication-title: Diabet. Med. doi: 10.1111/j.1464-5491.1992.tb01792.x – volume: 6 start-page: 1562 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0625 article-title: Design, Development and evaluation studies of buccal adhesive diltiazem tablets using natural edible mucoadhesives publication-title: Int. J. Pharmtech Res. – volume: 29 start-page: 640 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0290 article-title: Angiotensin II modulates BBB permeability via activation of the AT 1 receptor in brain endothelial cells publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2008.158 – volume: 238 start-page: 247 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0430 article-title: Characterization of human nasal primary culture systems to investigate peptide metabolism publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(02)00077-7 – volume: 147 start-page: 2088 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0295 article-title: Brain uptake of intranasally applied radioiodinated leptin in Wistar rats publication-title: Endocrinology doi: 10.1210/en.2005-1016 – volume: 435 start-page: 673 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0530 article-title: Oxytocin increases trust in humans publication-title: Nature doi: 10.1038/nature03701 – volume: 11 start-page: 971 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0210 article-title: Intranasal angiotensin II directly influences central nervous regulation of blood pressure publication-title: Am. J. Hypertens. doi: 10.1016/S0895-7061(98)00095-8 – volume: 87 start-page: 340 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0105 article-title: Intranasally applied l-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2011.11.004 – volume: 24 start-page: 565 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0950 article-title: Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2005.01.009 – volume: 255 start-page: 87 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0250 article-title: Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(03)00039-5 – volume: 86 start-page: 1144 year: 2001 ident: 10.1016/j.brainresbull.2018.10.009_bib0280 article-title: The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4–10) decreases body fat in humans publication-title: J. Clin. Endocrinol. Metabol. – volume: 68 start-page: 419 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0895 article-title: Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage publication-title: Pediatr. Res. – start-page: 43 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0275 article-title: Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(00)00540-9 – volume: 195 start-page: 44 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0165 article-title: Mechanism of intranasal drug delivery directly to the brain publication-title: Life Sci. doi: 10.1016/j.lfs.2017.12.025 – volume: 35 start-page: 789 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0140 article-title: Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-122308 – volume: 290 start-page: 1325 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0160 article-title: Reconstruction and morphometric analysis of the nasal airway of the dog (Canis familiaris) and implications regarding olfactory airflo publication-title: Anat. Rec. doi: 10.1002/ar.20592 – volume: 37 start-page: 737 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0665 article-title: In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain publication-title: Drug Dev. Ind. Pharm. doi: 10.3109/03639045.2010.539231 – volume: 2 start-page: 1502 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0875 article-title: Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats publication-title: Front Biosci (Elite Ed) doi: 10.2741/e209 – volume: 317 start-page: 40 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0915 article-title: Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2006.02.055 – volume: 73 start-page: 975 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0655 article-title: Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures publication-title: Indian J. Pediatr. doi: 10.1007/BF02758299 – volume: 7 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0800 article-title: Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa publication-title: BMC Pharmacol. doi: 10.1186/1471-2210-7-7 – volume: 17 start-page: 123 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0285 article-title: Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study publication-title: J. Child Neurol. doi: 10.1177/088307380201700206 – volume: 282 start-page: 212 year: 1981 ident: 10.1016/j.brainresbull.2018.10.009_bib0585 article-title: Clinical pharmacology: plasma protein binding of drugs publication-title: Br. Med. J. doi: 10.1136/bmj.282.6259.212 – volume: 2014 start-page: 1 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0720 article-title: Clinical pharmacology of midazolam in neonates and children: effect of disease—a review publication-title: Int. J. Pediatr. doi: 10.1155/2014/309342 – volume: 11 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0480 article-title: Improved intranasal retentivity and transnasal absorption enhancement by PEGylated poly-L-ornithine publication-title: Pharmaceuticals doi: 10.3390/ph11010009 – volume: 2 start-page: 105 year: 1990 ident: 10.1016/j.brainresbull.2018.10.009_bib0320 article-title: Animal models for intranasal drug delivery studies. A review article publication-title: Acta Pharm. Nord. – volume: 24 start-page: 1338 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0540 article-title: Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy publication-title: Drug Deliv. doi: 10.1080/10717544.2017.1377316 – volume: 20 start-page: 445 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0855 article-title: Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone publication-title: J. Clin. Psychopharmacol. doi: 10.1097/00004714-200008000-00009 – volume: 87 start-page: 187 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0450 article-title: Nasal drug delivery--possibilities, problems and solutions publication-title: J. Control. Release doi: 10.1016/S0168-3659(02)00363-2 – volume: 1 start-page: 35 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0125 article-title: Delivery of nerve growth factor to the brain via the olfactory pathway publication-title: J. Alzheimer’s Dis. doi: 10.3233/JAD-1998-1102 – volume: 437 start-page: 93 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0615 article-title: Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2008.04.003 – volume: 44 start-page: 1400 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0640 article-title: Intranasal fentanyl for acute severe pain episodes control in a dog publication-title: Vet. Anaesth. Analg. doi: 10.1016/j.vaa.2017.06.003 – volume: 321 start-page: 83 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0085 article-title: Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study publication-title: BMJ doi: 10.1136/bmj.321.7253.83 – volume: 27 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0715 article-title: Access to the olfactory region publication-title: Proc. Control. Release Bioact. Mater. – volume: 164 start-page: 747 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0435 article-title: Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy publication-title: Arch. Pediatr. Adolesc. Med. doi: 10.1001/archpediatrics.2010.130 – volume: 130 start-page: 127 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0955 article-title: Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat publication-title: Histochem. Cell Biol. doi: 10.1007/s00418-008-0410-2 – volume: 515 start-page: 1 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0330 article-title: Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2016.09.086 – volume: 61 start-page: 669 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0515 article-title: Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats publication-title: J. Pharm. Pharmacol. doi: 10.1211/jpp.61.05.0017 – volume: 5 start-page: 514 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0090 article-title: Sniffing neuropeptides: a transnasal approach to the human brain publication-title: Nat. Neurosci. doi: 10.1038/nn0602-849 – volume: 508 start-page: 22 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0235 article-title: Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2016.05.010 – volume: 379 start-page: 146 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0650 article-title: Nanoparticles for direct nose-to-brain delivery of drugs publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2009.06.019 – volume: 20 start-page: 47 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0730 article-title: Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach publication-title: Drug Deliv. doi: 10.3109/10717544.2012.752421 – volume: 3 start-page: 42 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0225 article-title: Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review publication-title: Drug Deliv. Transl. Res. doi: 10.1007/s13346-012-0108-9 – volume: 499 start-page: 81 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0305 article-title: Nanoparticle transport across in vitro olfactory cell monolayers publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2015.12.046 – volume: 35 start-page: 213 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0925 article-title: Formulation and device design to increase nose to brain drug delivery publication-title: J. Drug Deliv. Sci. Technol. doi: 10.1016/j.jddst.2016.05.003 – volume: 10 start-page: 957 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0725 article-title: Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2013.790887 – volume: 19 start-page: 998 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0260 article-title: Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles publication-title: Pharm. Res. doi: 10.1023/A:1016418523014 – volume: 121 start-page: 156 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0300 article-title: Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration publication-title: J. Control. Release doi: 10.1016/j.jconrel.2007.05.026 – volume: 64 start-page: 614 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0590 article-title: Intranasal delivery of biologics to the central nervous system publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2011.11.002 – volume: 25 start-page: 280 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0230 article-title: Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump publication-title: J. Aerosol Med. Pulm. Drug Deliv. doi: 10.1089/jamp.2011.0924 – volume: 13 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0880 article-title: A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies publication-title: PLoS One doi: 10.1371/journal.pone.0197101 – volume: 91 start-page: 522 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0400 article-title: Brief report: overweight humans are resistant to the weight-reducing effects of melanocortin4-10 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-0906 – volume: 22 start-page: 86 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0355 article-title: Functional evidence for P-glycoprotein at the nose-brain barrier publication-title: Pharm. Res. doi: 10.1007/s11095-004-9013-3 – volume: 105 start-page: 362 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0005 article-title: A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers publication-title: Epilepsy Res. doi: 10.1016/j.eplepsyres.2013.02.018 – volume: 9 start-page: 1173 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0255 article-title: Glucagon-like peptide-1 receptor is involved in learning and neuroprotection publication-title: Nat. Med. doi: 10.1038/nm919 – volume: 268 start-page: 364 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0510 article-title: Progress in brain targeting drug delivery system by nasal route publication-title: J. Control. Release doi: 10.1016/j.jconrel.2017.09.001 – volume: 5 start-page: 1159 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0960 article-title: From nose to brain: understanding transport capacity and transport rate of drugs publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.5.10.1159 – volume: 361 start-page: 128 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0010 article-title: Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2003.12.005 – volume: 67 start-page: 692 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0385 article-title: Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2009.09.020 – year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0050 – year: 1982 ident: 10.1016/j.brainresbull.2018.10.009_bib0755 – volume: 50 start-page: 86 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0555 article-title: In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2013.03.012 – volume: 93 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0660 article-title: Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig publication-title: J. Pharmacol. Sci. doi: 10.1254/jphs.93.437 – volume: 30 start-page: 2475 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0110 article-title: Intranasal treatment of central nervous system dysfunction in humans publication-title: Pharm. Res. doi: 10.1007/s11095-012-0915-1 – volume: 29 start-page: 1326 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0065 article-title: Intranasal insulin improves memory in humans publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2004.04.003 – volume: 5 start-page: 95 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0360 article-title: Drug transport at the blood-brain barrier and the choroid plexus publication-title: Curr. Drug Metab. doi: 10.2174/1389200043489126 – volume: 97 start-page: 1165 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0020 article-title: Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies publication-title: J. Pharm. Sci. doi: 10.1002/jps.21031 – volume: 29 start-page: 117 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0055 article-title: Optimization of systemic nasal drug delivery with pharmaceutical excipients publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00064-1 – volume: 2 start-page: 215 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0120 article-title: A review on mucoadhesive polymer used in nasal drug delivery system publication-title: J. Adv. Pharm. Technol. Res. doi: 10.4103/2231-4040.90876 – volume: 150 start-page: 23 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0335 article-title: Antiamnestic effects of antibodies to glutamate in experimental alzheimer’s disease publication-title: Bull. Exp. Biol. Med. doi: 10.1007/s10517-010-1058-1 – volume: 134 start-page: 173 year: 1996 ident: 10.1016/j.brainresbull.2018.10.009_bib0695 article-title: In vitro and in vivo nasal mucoadhesion of some water-soluble polymers publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)04416-7 – volume: 93 start-page: 1339 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0070 article-title: Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2007-2606 – volume: 35 start-page: 2403 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0560 article-title: Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.123 – volume: 302 start-page: 1062 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0040 article-title: Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.102.036129 – volume: 29 start-page: 157 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0550 article-title: Nasal delivery systems and their effect on deposition and absorption publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00067-7 – volume: 25 start-page: 3208 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0770 article-title: Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer’s disease-like pathology in amyloid precursor protein-transgenic mice publication-title: FASEB J. doi: 10.1096/fj.10-180133 – year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0825 – volume: 102 start-page: 46 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0395 article-title: Nose-to-brain transport of imatinib mesylate: a pharmacokinetic evaluation publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2017.02.032 – volume: 293 start-page: 1091 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0350 article-title: Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(24)39336-X – volume: 29 start-page: 3 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0685 article-title: Anatomy, physiology and function of the nasal cavities in health and disease publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00058-6 – start-page: 104 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0575 article-title: Compensatory responses to early olfactory restriction publication-title: Ann. New York Acad. Sci. doi: 10.1111/j.1749-6632.1998.tb10551.x – volume: 74 start-page: 290 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0935 article-title: RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2009.08.008 – volume: 10 start-page: 112 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0415 article-title: New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163 publication-title: Neuro. Oncol. doi: 10.1215/15228517-2007-052 – volume: 34 start-page: 355 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0075 article-title: Intranasal midazolam vs rectal diazepam in acute childhood seizures publication-title: Pediatr. Neurol. doi: 10.1016/j.pediatrneurol.2005.09.006 – volume: 22 start-page: 116 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0470 article-title: Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting publication-title: Alzheimer Dis. Assoc. Disord. doi: 10.1097/WAD.0b013e318157205b – volume: 58 start-page: 63 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0045 article-title: Carbamazepine uptake into rat brain following intra-olfactory transport publication-title: J. Pharm. Pharmacol. doi: 10.1211/jpp.58.1.0008 – volume: 8 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0150 article-title: A novel approach to reinstating tolerance in experimental autoimmune myasthenia gravis using a targeted fusion protein, mCTA1-T146 publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.01133 – volume: 325 start-page: 513 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0710 article-title: Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.107.132381 – volume: 9 start-page: 566 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0315 article-title: Anatomical and histological factors affecting intranasal drug and vaccine delivery publication-title: Curr. Drug Deliv. doi: 10.2174/156720112803529828 – volume: 34 start-page: 381 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0840 article-title: NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2009.02.011 – volume: 63 start-page: 762 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0205 article-title: Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.02860 – volume: 2014 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0830 article-title: Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation publication-title: Biomed Res. Int. doi: 10.1155/2014/156010 – volume: 260 start-page: 470 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0885 article-title: A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures publication-title: J. Neurol. doi: 10.1007/s00415-012-6659-3 – volume: 69 start-page: 29 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0155 article-title: Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial publication-title: Arch. Neurol. doi: 10.1001/archneurol.2011.233 – volume: 22 start-page: 425 year: 1999 ident: 10.1016/j.brainresbull.2018.10.009_bib0325 article-title: Intranasal administration of diazepam aiming at the treatment of acute seizures: clinical trials in healthy volunteers publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.22.425 – volume: 51 start-page: 364 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0445 article-title: Saturable leptin transport across the BBB persists in EAE mice publication-title: J. Mol. Neurosci. doi: 10.1007/s12031-013-9993-8 – volume: 144 start-page: 813 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0545 article-title: A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse publication-title: Endocrinology doi: 10.1210/en.2002-220982 – year: 1983 ident: 10.1016/j.brainresbull.2018.10.009_bib0815 article-title: Nasal airway anatomy and inhalation deposition in experimental animals and people – volume: 17 start-page: 316 year: 1994 ident: 10.1016/j.brainresbull.2018.10.009_bib0440 article-title: Evaluation of enhancers to increase nasal absorption using Ussing chamber technique publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.17.316 – year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0310 – volume: 53 start-page: 1187 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0675 article-title: Comparison of two US sheep scrapie isolates supports identification as separate strains publication-title: Vet. Pathol. doi: 10.1177/0300985816629712 – volume: 32 start-page: 428 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0345 article-title: Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate publication-title: Peptides doi: 10.1016/j.peptides.2010.10.030 – volume: 29 start-page: 13 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0635 article-title: Nasal mucociliary clearance as a factor in nasal drug delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00059-8 – volume: 151 start-page: 66 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0785 article-title: Intranasal administration of interferon β bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2004.02.011 – ident: 10.1016/j.brainresbull.2018.10.009_bib0700 – volume: 102 start-page: 3811 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0190 article-title: Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0500195102 – volume: 54 start-page: 1389 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0420 article-title: Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(03)00465-7 – volume: 69 start-page: 573 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0900 article-title: Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2006.02.020 – volume: 46 start-page: 4 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0805 article-title: Brain insulin signaling and Alzheimer’s disease: current evidence and future directions publication-title: Mol. Neurobiol. doi: 10.1007/s12035-011-8229-6 – volume: 2 start-page: 173 year: 1984 ident: 10.1016/j.brainresbull.2018.10.009_bib0680 article-title: Anatomy and physiology of the nose-pathophysiologic alterations in allergic rhinitis publication-title: Clin. Rev. Allergy doi: 10.1007/BF02991098 – volume: 2 start-page: 1322 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0130 article-title: Advantageous nasal drug delivery system: a review publication-title: Int. J. Pharm. Sci. Res. – volume: 10 start-page: 1365 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0030 article-title: Are the extracelluar pathways a conduit for the delivery of therapeutics to the brain? publication-title: Curr. Pharm. Des. doi: 10.2174/1381612043384862 – volume: 20 start-page: 1225 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0365 article-title: P-glycoprotein attenuates brain uptake of substrates after nasal instillation publication-title: Pharm. Res. doi: 10.1023/A:1025053115583 – volume: 5 start-page: 213 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0850 article-title: Preliminary pharmaceutical characterization of some flowers as natural indicator publication-title: Pharma Res. – volume: 7 start-page: 4169 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0820 article-title: Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies publication-title: Acta Biomater. doi: 10.1016/j.actbio.2011.07.025 – volume: 20 start-page: 1341 year: 1999 ident: 10.1016/j.brainresbull.2018.10.009_bib0035 article-title: Impaired transport of leptin across the blood-brain barrier in obesity publication-title: Peptides doi: 10.1016/S0196-9781(99)00139-4 – volume: 135 start-page: 83 year: 1982 ident: 10.1016/j.brainresbull.2018.10.009_bib0380 article-title: Comparative morphometry of the nasal cavity in rats and mice publication-title: J. Anat. – volume: 27 start-page: 451 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0775 article-title: Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2005.03.016 – volume: 32 start-page: 1217 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0835 article-title: Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain publication-title: Peptides doi: 10.1016/j.peptides.2011.03.016 – volume: 359 start-page: 366 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0790 article-title: Intranasal opioid administration in Rhesus monkeys: PET imaging and antinociception publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.116.235192 – volume: 30 start-page: 295 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0115 article-title: Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2006.11.018 – volume: 12 start-page: 565 year: 1995 ident: 10.1016/j.brainresbull.2018.10.009_bib0945 article-title: Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions publication-title: Pharm. Res. doi: 10.1023/A:1016210231121 – volume: 11 start-page: 1550 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0180 article-title: Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles publication-title: Mol. Pharm. doi: 10.1021/mp400735c – volume: 7 start-page: 967 year: 2002 ident: 10.1016/j.brainresbull.2018.10.009_bib0015 article-title: Permeability issues in nasal drug delivery publication-title: Drug Discov. Today doi: 10.1016/S1359-6446(02)02452-2 – volume: 3 start-page: 123 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0580 article-title: Transepithelial electrical measurements with the Ussing chamber publication-title: J. Cyst. Fibros. doi: 10.1016/j.jcf.2004.05.026 – volume: 105 start-page: 1209 year: 2016 ident: 10.1016/j.brainresbull.2018.10.009_bib0605 article-title: Development and evaluation of a novel intranasal spray for the delivery of amantadine publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2015.12.016 – volume: 57 start-page: 97 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0905 article-title: Study on brain targeting of raltitrexed following intranasal administration in rats publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-005-0018-3 – volume: 9 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0535 article-title: Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types publication-title: Front. Pharmacol. doi: 10.3389/fphar.2018.00027 – volume: 131 start-page: 2734 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0025 article-title: Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (hypocretin-1) publication-title: Brain doi: 10.1093/brain/awn193 – volume: 108 start-page: 1204 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0425 article-title: Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults publication-title: Epilepsy Res. doi: 10.1016/j.eplepsyres.2014.04.007 – volume: 2 start-page: 96 year: 2001 ident: 10.1016/j.brainresbull.2018.10.009_bib0170 article-title: The renin–angiotensin system in the brain: an update publication-title: J. Renin Angiotensin Aldosterone Syst. doi: 10.3317/jraas.2001.019 – volume: 82 start-page: 937 year: 1995 ident: 10.1016/j.brainresbull.2018.10.009_bib0095 article-title: SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat publication-title: Cell doi: 10.1016/0092-8674(95)90273-2 – volume: 91 start-page: 7114 year: 1994 ident: 10.1016/j.brainresbull.2018.10.009_bib0750 article-title: Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.91.15.7114 – volume: 37 start-page: 294 year: 1985 ident: 10.1016/j.brainresbull.2018.10.009_bib0410 article-title: Intranasal drug delivery by spray and drops publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1985.tb05069.x – volume: 14 start-page: 75 year: 2001 ident: 10.1016/j.brainresbull.2018.10.009_bib0175 article-title: Levels of dopamine in blood and brain following nasal administration to rats publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(01)00151-8 – volume: 27 start-page: 14239 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0195 article-title: Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3878-07.2007 – volume: 263 start-page: 1 year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0910 article-title: Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(03)00341-7 – volume: 25 start-page: 11489 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0520 article-title: Oxytocin modulates neural circuitry for social cognition and fear in humans publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3984-05.2005 – volume: 13 start-page: 14127 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0600 article-title: Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms131114127 – volume: 3 start-page: 267 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0465 article-title: Applications of microemulsion based drug delivery system publication-title: Curr. Drug Deliv. doi: 10.2174/156720106777731118 – volume: 11 start-page: 1 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0455 article-title: Transport of drugs from the nasal cavity to the central nervous system publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(00)00087-7 – volume: 302 start-page: 133 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0485 article-title: Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.06.012 – volume: 43 start-page: 221 year: 1988 ident: 10.1016/j.brainresbull.2018.10.009_bib0745 article-title: The influence of solution viscosity on nasal spray deposition and clearance publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(88)90277-3 – volume: 23 start-page: 391 year: 2000 ident: 10.1016/j.brainresbull.2018.10.009_bib0495 article-title: Brain uptake and the analgesic effect of oxytocin--its usefulness as an analgesic agent publication-title: Arch. Pharm. Res. doi: 10.1007/BF02975453 – volume: 11 start-page: 827 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0630 article-title: Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2014.894504 – volume: 47 start-page: 6 year: 2012 ident: 10.1016/j.brainresbull.2018.10.009_bib0270 article-title: Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2012.04.013 – volume: 446 start-page: 30 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0920 article-title: Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2008.09.030 – volume: 26 start-page: 1911 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0865 article-title: A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs publication-title: Pharm. Res. doi: 10.1007/s11095-009-9907-1 – volume: 461 start-page: 212 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0965 article-title: The doseeffectiveness of intranasal VEGF in treatment of experimental stroke publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2009.06.060 – volume: 22 start-page: 235 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0370 article-title: Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation publication-title: Pharm. Res. doi: 10.1007/s11095-004-1191-5 – volume: 18 start-page: 338 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0980 article-title: Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia publication-title: Drug Deliv. doi: 10.3109/10717544.2011.557785 – year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0705 article-title: Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage publication-title: Stem Cells Dev. doi: 10.1089/scd.2017.0148 – volume: 10 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0860 article-title: Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting publication-title: Pharmaceutics doi: 10.3390/pharmaceutics10010034 – volume: 103 start-page: 254 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0460 article-title: Bioavailability of Intranasal vs. Rectal Diazepam publication-title: Epilepsy Res. doi: 10.1016/j.eplepsyres.2012.07.018 – volume: 449 start-page: 108 year: 2009 ident: 10.1016/j.brainresbull.2018.10.009_bib0975 article-title: Direct transport of VEGF from the nasal cavity to brain publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2008.10.090 – volume: 134 start-page: 79 year: 2017 ident: 10.1016/j.brainresbull.2018.10.009_bib0570 article-title: Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2017.07.006 – volume: 9 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0405 article-title: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease publication-title: BMC Neurosci. doi: 10.1186/1471-2202-9-S3-S5 – volume: 5 start-page: 253 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0620 article-title: Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children publication-title: Epilepsy Behav. doi: 10.1016/j.yebeh.2004.01.003 – year: 1978 ident: 10.1016/j.brainresbull.2018.10.009_bib0375 – volume: 47 start-page: 715 year: 2015 ident: 10.1016/j.brainresbull.2018.10.009_bib0795 article-title: Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-150307 – volume: 9 start-page: 2241 year: 2014 ident: 10.1016/j.brainresbull.2018.10.009_bib0595 article-title: Current approaches to enhance CNS delivery of drugs across the brain barriers publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S61288 – volume: 2 start-page: 3 year: 2005 ident: 10.1016/j.brainresbull.2018.10.009_bib0735 article-title: The blood-brain barrier: bottleneck in brain drug development publication-title: NeuroRx doi: 10.1602/neurorx.2.1.3 – volume: 29 start-page: 51 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0810 article-title: In vitro cell models to study nasal mucosal permeability and metabolism publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00061-6 – volume: 101 start-page: 9855 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0220 article-title: Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0403172101 – volume: 48 start-page: 557 year: 1999 ident: 10.1016/j.brainresbull.2018.10.009_bib0505 article-title: Central nervous system effects of intranasally administered insulin during euglycemia in men publication-title: Diabetes doi: 10.2337/diabetes.48.3.557 – volume: 61 start-page: 731 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0240 article-title: Oxytocin improves “Mind-Reading” in humans publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.07.015 – volume: 60 start-page: 114 year: 2011 ident: 10.1016/j.brainresbull.2018.10.009_bib0060 article-title: Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men publication-title: Diabetes doi: 10.2337/db10-0329 – volume: 12 start-page: 2755 year: 2015 ident: 10.1016/j.brainresbull.2018.10.009_bib0645 article-title: Nose-to-Brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.5b00088 – volume: 15 start-page: 219 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0500 article-title: Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers publication-title: Drug Deliv. doi: 10.1080/10717540802006377 – volume: 54 start-page: 14 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0930 article-title: Applied anatomy and physiology of the nose and paranasal sinuses publication-title: Allergy doi: 10.1111/j.1398-9995.1999.tb04402.x – volume: 3 start-page: 1 year: 2013 ident: 10.1016/j.brainresbull.2018.10.009_bib0890 article-title: Nasal drug delivery publication-title: Drug Deliv. Transl. Res. doi: 10.1007/s13346-012-0111-1 – volume: 99 start-page: 1654 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0215 article-title: Intranasal delivery to the central nervous system: mechanisms and experimental considerations publication-title: J. Pharm. Sci. doi: 10.1002/jps.21924 – start-page: 373 year: 1998 ident: 10.1016/j.brainresbull.2018.10.009_bib0670 article-title: The human vomeronasal system: a review publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1998.tb10595.x – volume: 11 start-page: 295 year: 2004 ident: 10.1016/j.brainresbull.2018.10.009_bib0690 article-title: Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits publication-title: Drug Deliv. J. Deliv. Target. Ther. Agents – volume: 30 start-page: 946 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0525 article-title: Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.109.202671 – volume: 55 start-page: 64 year: 2007 ident: 10.1016/j.brainresbull.2018.10.009_bib0265 article-title: Olfactory transfer of analgesic drugs after nasal administration publication-title: Digit. Compr. Summ. Uppsala Diss. from Fac. Pharm. – volume: 51 start-page: 478 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0185 article-title: A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations publication-title: Epilepsia doi: 10.1111/j.1528-1167.2009.02333.x – volume: 9 year: 2008 ident: 10.1016/j.brainresbull.2018.10.009_bib0610 article-title: Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone publication-title: BMC Neurosci. doi: 10.1186/1471-2202-9-117 – volume: 49 start-page: 303 year: 2015 ident: 10.1016/j.brainresbull.2018.10.009_bib0475 article-title: Intranasal therapies for acute seizures publication-title: Epilepsy Behav. doi: 10.1016/j.yebeh.2015.04.027 – year: 2003 ident: 10.1016/j.brainresbull.2018.10.009_bib0145 article-title: Anatomy of the human nasal passages – volume: 207 start-page: 428 year: 2018 ident: 10.1016/j.brainresbull.2018.10.009_bib0760 article-title: Intranasal delivery of a novel acetylcholinesterase inhibitor HLS-3 for treatment of Alzheimer’s disease publication-title: Life Sci. doi: 10.1016/j.lfs.2018.06.032 – volume: 68 start-page: 342 year: 2010 ident: 10.1016/j.brainresbull.2018.10.009_bib0490 article-title: Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders publication-title: Ann. Neurol. doi: 10.1002/ana.22070 – volume: 13 start-page: 870 year: 2006 ident: 10.1016/j.brainresbull.2018.10.009_bib0565 article-title: Intranasal administration of the growth-compromised HSV-2 vector ΔRR prevents kainate-induced seizures and neuronal loss in rats and mice publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2005.12.013 |
| SSID | ssj0006856 |
| Score | 2.6855843 |
| SecondaryResourceType | review_article |
| Snippet | [Display omitted]
•The two main pathways of intranasal drug absorption are the olfactory and trigeminal routes.•The intranasal drugs can bypass the blood-brain... The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 155 |
| SubjectTerms | CNS indication Delivery enhancer techniques Drug delivery Intranasal administration Transporter interactions |
| Title | Evaluation of intranasal delivery route of drug administration for brain targeting |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0361923018303678 https://dx.doi.org/10.1016/j.brainresbull.2018.10.009 https://www.ncbi.nlm.nih.gov/pubmed/30449731 https://www.proquest.com/docview/2135643915 |
| Volume | 143 |
| WOSCitedRecordID | wos000452813700018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection customDbUrl: eissn: 1873-2747 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006856 issn: 0361-9230 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6jQdeEDBg5TIZie2lyhTn6gjxUI1OgKqCUIf6FjmOM60rSUnbaeMH8Ls5tmOnFUwqD7xEVSy3tc_nc_G5IfQm9KMIDGXZgJh5ThAk3Mlo4DlJUXCQVoUfqeDxb8N4NKKTSfKl0_llcmGuZ3FZ0pubZP5fSQ3vgNgydfYfyG2_FF7AZyA6PIHs8NyK8ANbv7spBwHSiC2kL0bMZBDGba-umuCAvF5d9NhG-Vwdvin7RvR0kLgRbbYIElMZMM1tSbZevVsq5nV-dBoeJcQoxfxycdXa_JVuyDZccdaTpZstelh9pTPL3ivPPZF57-0l6_SnUnHlECUXpdi4qyDURr0Z9kpj35F2sJY-f3lneHLgr3FVoiv5_sHt9cXD9ETtCqxcrllG69ETFbCXtDLO-PVHn9Oz8-EwHQ8m4-P5D0d2H5Ne-qYVyw7a8-IwAe641_84mHyyMj2iqg-w_a-mfK2KFLzr5-9Sde4yZZRKM36IHjS2CO5rDD1CHVE-Rvv9ki2r77f4GKvoYOV22UdfW1jhqsAtrLCBFVawkoMSVngTVhhghdUKsIXVE3R-NhiffnCafhwOD8N4CYfYk-YypVmRkyzjNMrcMOchETJ7WQQ8YcyNeeZmcMg9moMxAdp7xAswClgGeuVTtFtWpThAOAq4IG4e-oIVQS5YRvI8SCj3GHELjwRdlJitS3lTrF72TJmlJipxmq5veyq3XY7BtneRb-fOdcmWrWa9NRRKTVIyiNEUsLbV7Hd2dqO6apV06_mvDShS4O_SacdKUa0WqUf8UKXHh130TKPFrsp3gbnGPnm-xewX6H57Il-i3WW9Eq_QPX69vFzUh2gnntDDBvW_AaJ206Q |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+intranasal+delivery+route+of+drug+administration+for+brain+targeting&rft.jtitle=Brain+research+bulletin&rft.au=Erd%C5%91%2C+Franciska&rft.au=Bors%2C+Luca+Anna&rft.au=Farkas%2C+D%C3%A1niel&rft.au=Bajza%2C+%C3%81gnes&rft.date=2018-10-01&rft.issn=1873-2747&rft.eissn=1873-2747&rft.volume=143&rft.spage=155&rft_id=info:doi/10.1016%2Fj.brainresbull.2018.10.009&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0361-9230&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0361-9230&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0361-9230&client=summon |